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INTRODUCTION 
 Hepatitis is the condition characterized by the presence of 
inflammatory cells in the liver tissue. It is caused by different etiological 
agents and is more commonly used to refer to a group of viral infections 
that affects liver, such as hepatitis A, B, C, D and E. Hepatitis A and E 
are transmitted through feco-oral route, hepatitis B and C are transmitted 
through infected blood and body fluids and hepatitis D occur exclusively 
in persons infected with hepatitis B virus.   
All water borne epidemics of viral hepatitis was thought to be 
caused by hepatitis A virus. In Delhi there was a suspected outbreak of 
hepatitis A between 1955 and 1956. Serum samples from those patients 
were collected and preserved. In 1983 a specific and sensitive assay was 
applied to these preserved samples and they were found to be negative for 
specific antibodies against hepatitis A virus4. Thus a new clinical entity 
came into life with signs and symptoms similar to other forms of viral 
hepatitis. 
It was designated as hepatitis E because of its enteric transmission, 
epidemic and endemic nature that capture the hepatitis E virus1. Later it 
was known as Enterically Transmitted Non A Non B (ENANB) hepatitis 
or Epidemic Non A Non B5.  
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Hepatitis E virus (HEV) causes large outbreaks in endemic areas 
like India, Central Asia, parts of Africa and Mexico1. It is the most 
important cause of epidemic and sporadic viral borne hepatitis in 
countries with suboptimal sanitary conditions affecting susceptible 
population like young aged adults and pregnant women.  
Prevalence of Hepatitis E in developing countries ranges from 
7.2% to 24.5% when compared to <1% in developed countries25,32.  
Hepatitis E virus causes an acute short lived, self-limiting viral 
hepatitis typically lasting for 1-4 weeks. Itaffects both sexes targeting age 
group between 15 and 40.It exhibits a wide clinical spectrum, fluctuating 
from asymptomatic infection to fulminant hepatitis. Most cases of 
pregnancy will not affect the severity of hepatitis unless it is found to be 
hepatitis E which tends to worsen during the period of pregnancy. It 
causes fulminant hepatic failure (FHF) in pregnant women particularly 
those in 2nd and 3rd trimester of pregnancy. There is a high rate of 
occurrence of disseminated intravascular coagulation (DIC) associated 
with hepatitis E infection in pregnancy27.Attack rate among 1st, 2nd and 3rd 
trimester were 8.8%, 19.4% and 18.6% respectively. Whereas among 
non-pregnant women and men it is only 2.1% and 2.8%2.  
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37% of acute viral hepatitis during pregnancy is caused by hepatitis 
E and 81% of them go in for fulminant hepatic failure more commonly 
during 3rdtrimester of pregnancy20,22.  General mortality rate in hepatitis E 
is 1 to 2 percentage when compared with hepatitis A which is 0.4 
percentage1.  
The case fatality rate among pregnant mothers is 25% 4,22,25 and has 
been reported to be very high with maximum severity in the third 
trimester of pregnancy i.e. 44.4%2 .In fact, the major cause of mortality in 
epidemics is due to the high rate of fulminant hepatic failure in pregnant 
women27.Besides the high maternal mortality rate, the other dangers of 
fulminant hepatic failure such as fetal malformation, abortion, still birth 
and neonatal death are noted among pregnant mothers with hepatitis E 
infection4,25. 
High rates of vertical transmission of hepatitis E were documented 
between 33.3% and 50% leading to high fetal mortality25. Studies have 
reported that 78.9% of babies had evidence of vertically transmitted HEV 
infection30. This data points to a relationship between severity of HEV 
infection in the pregnant women and the fetus. 
Most of the cases of hepatitis E remain asymptomatic. The 
treatment of acute infection is supportive management. In spite of the 
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explosive nature of hepatitis E during pregnancy, there is no established 
treatment available for it31. Therapeutic termination of pregnancy as 
approved in disorders like HELLP syndrome have not been completely 
explored in hepatitis E infection19. The diagnosis of hepatitis E infection 
in individual patients remains challenging. It cannot be clinically 
distinguished from other forms of acute viral hepatitis. The routine 
laboratory diagnosis of hepatitis E is based either on serologic tests or 
nucleic acid amplification techniques27.  
Trials of HEV vaccines are presently continuing in many countries. 
This consists of a candidate vaccine which is very effective and accepted 
in China, showing efficacy of >90%. On January 23,2012 this vaccine has 
been licensed by State Food and Drug Administration of China for its 
production and sale. Perhaps it is a major milestone on the road towards 
protecting susceptible women in a disease endemic country like India.  
Hepatitis E is accountable for approximately 9.8% of pregnancy 
associated deaths. In southern Asia, as many as 10,500 maternal deaths 
per year could be prevented by using the existing vaccine24. With the 
availability of an efficacious vaccine, we must consider prudent 
implementation of such an intervention, where appropriate, to avoid a 
significant proportion of preventable deaths in developing countries. 
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As there is very less data documented with respect to sero-
prevalence of hepatitis E in pregnant mothers in India, this study was 
done to assess the sero-prevalence of subclinical hepatitis E viral 
infection in asymptomatic pregnant mothers attending routine antenatal 
check up in a tertiary care hospital in Chennai. Moreover, it helps in 
considering vaccination for the pregnant mothers and development of 
existing vaccine.  
Since hepatitis E infection is a significant health problem world, 
there is a need for more public health involvement by provision of clean 
drinking water, health education of public and easy availability of 
approved serological assay for early detection of infection. 
  
  
 
AIMS  
AND  
OBJECTIVES 
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AIMS AND OBJECTIVE 
 
1) To study the seroprevalence of Hepatitis E virus infection in 
asymptomatic pregnant mothers attending routine antenatal 
check up in a tertiary care hospital in Chennai. 
 
2) To emphasize the importance of screening, diagnosis and 
management of HEV infection in asymptomatic pregnant 
women  
 
3) To study the implications of HEV vaccination if available in 
the future to all sero-negative antenatal mothers thereby 
decreasing morbidity and mortality associated with HEV 
infection 
 
  
  
 
REVIEW  
OF  
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REVIEW OF LITERATURE 
HEPATITIS E VIRUS 
THE DISCOVERY 
The clinical features of viral hepatitis wasrecognized by 
Hippocrates in 460-375 BC. In the year 1965, Blumberg et al discovered 
Australia antigen which consequently led to the detection of hepatitis B 
virus. In 1973, Feinstone et al demonstrated hepatitis A virus by immune 
electron microscopy (IEM) in stool extracts of patients with acute 
hepatitis A virus infection. Later, Choo et al identified hepatitis C virus 
from post-transfusion patients, and developed serological test for its 
diagnosis. 
Till 1980 all water borne epidemic viral hepatitis disease were 
thought to be caused by hepatitis A. During the 1955-56 epidemic, about 
29,300 patients developed symptoms of jaundice in Delhi which was 
typical of hepatitis A disease by Indian Council of Medical Research13 
and concluded that, the disease caused by a hepatitis virus, lasting for less 
than 6 weeks spread through contaminated water and was of non-A, non-
B. They also concluded that the disease typically affected the young 
adults with maximum  severity in pregnant women. 
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The experimental evidence of hepatitis E was first reported by 
Balayan et al5 in the year 1983.He successfully demonstrated the fecal-
oral transmission of hepatitis. A volunteer who was already infected with 
hepatitis A infection in the past was given a suspension inoculated with 
feces specimen collected from the patient from Uzbekistan5. On 36th day, 
the volunteer developed clinical feature of severe hepatitis and the fecal 
sample showed27 to 30 nm sized virus like particles in a immune electron 
microscopy (IME)5.  
Balayan observed that the volunteer did not develop antibodies to 
either HAV or HBV but to virus like particles which he detected from his 
faeces5, 6. The study members also demonstrated a similar transmission of 
HEV in cynomolgus monkey with the volunteer’s faecal sample and the 
monkeys responded similarly5. 
This type of non-A non-B hepatitis was designated as enterically 
transmitted nonA nonB (ENANB) hepatitis or epidemic nonAnonB. Later 
it was found to be the major hidden cause for epidemics in many 
developing countries and also cause sporadic cases of hepatitis. 
In those days Immune Electron microscopy and transmission to 
primates were the only means of studying HEV. 
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CLASSIFICATION 
HEV is an RNA virus of the Hepeviridae family, genus Hepevirus5 
as classified by Emerson et al, 20065. 
HEPATITIS E VIRUS 
 
Fig 3.1 Hepatitis E structure 
Hepatitis E viruses are small, 27-34 nm in diameter, symmetrical 
icosahedral, non-enveloped, with non-segmented positive-sense, single 
stranded, polyadenylated RNA (at its 3’ terminus) comprising of a 7.5 kb 
genome4, 7. 
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GENOTYPE AND PREVALENCE OF HEPATITIS E HUMAN 
STRAIN 
Genotyping became prevalent during the mid-1990’s22. Based on 
sequence analysis done from the hepatitis E strains from different parts of 
the world, HEV were known to have 4strains i.e., I, II, III, IV5. Upto  
9 genotypes have been dicovered6. 
Further phylogenetic analysis showed multiple subtypes in each 
genotype. HEV I into 5 subtypes, II into 2 subtypes, III into 10 and IV 
into 7 subtypes7.  
Genotype I   – Asia(India, Pakistan), North Africa 
Genotype II – Mexico, South Africa 
Genotype III - North and South America, Europe, Asia 
Genotype IV – Asia (China, Taiwan, Vietnam, Japan) 
 Genotype I and II cause hepatitis outbreaks especially in 
developing countries and Genotype I is the most common subtype in 
India.  
Genotype I contains human hepatitis Estrains obtained from 
endemic regions. Limited sequence strains appears to belong to genotype 
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II. Genotype III and IV have been identified from human and swine 
sources6. 
MOLECULAR CHARACTERIZATION OF THE VIRUS 
 Most of the molecular aspects of hepatitis Ewere gained by in vitro 
expression of recombinant proteins due to the lack of efficient cell culture 
system. 
 
Fig 3.2: RNA of HEV virus 
OPEN READING FRAME (ORF 1) 
ORF1 begins at the 5’ terminus of the hepatitis E. It contains 5,073 
to 5,124 nucleotides long codes for nonstructural proteins (polyproteins 
with length of 1693 amino acid) that are involved in replication of viral 
genome and viral protein processing4, 5,7.  
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OPEN READING FRAME 2 (ORF2) 
ORF 2 begins at 37nt 3’ of the termination coding frame of ORF1. 
It has 1977 to 1,980 nucleotides 5 and encodes for the main structural 
viral capsid proteins. In addition to the fresh virions, ORF2 forms 30 
small sized icosahedral homodimers (size and modification are not yet 
determined)5,6,7.   
Hepatitis Evirus envelope protein form the Virus like Protein 
(VLP). These particles have been characterized with the help of 3-D 
reconstruction of the structure and Cryo-electron microscopy.  
OPEN READING FRAME 3 (ORF3) 
 ORF3 is the smallest and last open reading frame with 366 to 369 
nucleotides encodes and encodes for pORF protein (123 amino acid) 
expressed in an intracellular manner, shown to be associated with liver 
cell cytoskeleton in HIV replication4, 6.    
Other aspects such as assembly and release of viral progeny, some 
viral protein synthesis, HEV genomic transcription remains unclear. 
KEY ANTIGENS5 
 HEV antigens are reactive in immune electron microscopy, enzyme 
linked immunosorbent assay (ELISA), western blot and 
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immunofluorescent microscopy. ORF3 is more heterogeneous, whereas 
ORF2 is highly conserved relatively and hence the ORF2 sequence based 
serological test are broadly reactive and tests containing ORF3 are more 
strain specific.  
Expressed or synthetic peptides of ORF2 and ORF3 are used in 
diagnostic tests like ELISA and Western blot. Truncated proteins 
expressed from ORF2 in insect cells are better than proteins expressed in 
Escherichia coli for detecting antibodies against hepatitis E virus, though  
not satisfactorily sensitive for sero-epidemiological studies5.  
ORF1 incorporated test are not useful for routine diagnostic 
purposes, however, important for distinguishing infection-induced and 
vaccine induced immune response when non replicating hepatitis E 
vaccines are available commercially5. 
REPLICATION OF HEPATITIS E VIRUS 
 Little information is known about the stages of replication because 
hepatitis E virus is not closely related to any other well characterized 
virus and reports from conventional cell culture are insufficient about its 
strategy of replication5, 6.  
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However, recently, replication of hepatitis E virus have been 
documented in primary cell cultures of hepatocytes obtained from 
cynomologus monkeys already infected in vivo. The process of 
attachment, entry and uncoating of hepatitis E virus is not determined 
because of limited availability and absence of characterized and 
permissive cell culture5, 6. 
 It is assumed that hepatitis E virus attaches to the receptors on 
hepatocytes especially in the biliary tract and intestine. From the newly 
uncoated virus particle, 7.2-kb genome is released. The nonstructural 
proteins recognizes the capped 5’RNA after presumably translated via 
cellular mechanisms5,6 and the required enzymes are provided for the 
synthesis of both positive and negative strand RNA.  
Cellular proteases are found to cleave ORF1 that is sequenced with 
papain like protease motif, but its functions are not yet clear.  
3’ end of the viral genome shown to bind with RNA dependent 
RNA polymerase and ORF 2 binds to the first 76 nucleotide of the 5’ 
region6.  
Positive sense full length genomic RNA and 2 bicistronic 
subgenomic mRNA of 3.7 and 2.0kb are transcribed from replicative full 
length negative strand RNA5,6. 
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However, the importance of these subgenomic RNAs in translation 
of ORF2 and ORF3 protein are not determined. Nothing is known about 
how these processes are regulated6. 
HEPATITIS E VIRUS TRANSMISSION 
Hepatitis E virus is classified as the transmitter of waterborne and 
foodborne diseases11. Most common route of transmission is feco-oral. 
Most of the epidemic serologically confirmed for hepatitis Evirus have 
been found to be linked with fecal contamination of drinking water. Some 
sporadic hepatitis have been associated with consumption of undercooked 
pork or raw/uncooked shellfish7. Consumption of undercooked or raw 
meat of infected pork, beef, wild boar meat and offal are significantly 
associated with hepatitis Einfection12.  
The spread of hepatitis E virus infection from cases to contact by 
person to person contact and fomites may play a role, but this is not 
always common4. This may be due to the low amount of intact hepatitis E 
particles present in a patient’s stool16.Transmission of hepatitis Evirus 
infection through person to person contact between family members is 
only one to two percentage compared to fifteen percentage in  
hepatitis A7.  
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Transmission via exposure to infected blood has been reported in 
endemic regions. Post transfusion hepatitis E infection have also been 
documented 28. Trans-placental transmission of hepatitis E virus in third 
trimester of pregnancy is associated high perinatal mortality of the 
newborns14.There appears to be relatively higher risk among infants born 
to mothers with hepatitis E infection upto 33.3% of cases20. In a study of 
469 pregnant women with hepatitis E infection, found to have vertical 
transmission up to 100%19. 
 Though hepatitis E virus RNA is detected in the colostrum milk, 
no evidence suggest the spread of infection to offspring1. There is no 
evidence for HEV transmission through sexual route4. Hepatitis E 
infection has also been documented in 3 health care workers who had 
treated fulminant hepatic failure due to hepatitis E in South Africa4. 
Travelling history to HEV endemic region pose a high risk factor in a 
number of cases. 
Improper treatment of drinking water and substandard sanitation is 
the major cause for hepatitis E virus outbreaks.  
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PATHOGENESIS AND PATHOLOGY 
PRIMARY HOST TARGET CELLS FOR HEV- 
HEPATOCYTES4,5,6,28 
The pathogenesis of Hepatitis E virus infection is not completely 
understood so far due to the lack of competent cell culture system. Most 
of the little knowledge about the pathogenesis of hepatitis E virus was 
obtained from the studies on non-human primates28. However, from the 
clinical picture and its serological events exhibited in some of the typical 
cases of hepatitis E disease, certain speculative conclusion have been 
arrived at about its pathogenesis. Ingestion of contaminated food with 
infected patient’s faeces is the route of primary entry of HEV into the 
host5. 
It is presumed that hepatitis E virus replication takes place in the 
intestinal tract. It reaches the hepatocytes and starts replicating within the 
cytoplasm, followed by a phase of viremia with high concentration of the 
virus found in bile and is shed in the feces. Transient viraemia occurs for 
3-4 weeks. Anti HEV IgM peaks with the symptomatic period and persist 
for 3 to 6 months and after that they become undetectable.  
Anti HEV IgG appears 3 to 4 weeks post inection and have been 
shown to persist for 2 to 13 years. During convalescent period IgG 
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disappears within 6 to 12 months period1.HEV RNA are detected in the 
biliary duct, on the luminal aspect of the epithelial cell surfaceusing in 
situ hybridisation7.Hepatitis E virus antigens are expressed in the 
hepatocyte cytoplasm, faeces and bile. Antigens appears one week post 
infection indicating viral replication. HEV can be detected in the stool a 
week prior to the clinical symptoms.  
It has been established that the liver injury is caused by the 
immune response produced by the host to the invading hepatitis Eand 
does not depend directly on the replication of the virus in the liver tissue. 
Viraemia and faecal shedding is followed by the onset of alanine 
transaminase (ALT) elevation. Observable histopathological changes in 
the liver usually correspond to the detectable levels of antibodies to 
hepatitis Ein the serum and decreased levels of hepatitis Evirus antigens 
in the hepatocytes of the liver.  
 During epidemic outbreaks of hepatitis Edisease, examination of 
the infected patient’s liver shows either a characteristic cholestatic pattern 
with glandular modification of the parenchymal cells or a pattern similar 
to the other forms of acute viral hepatitis which includes acidophilic 
bodies formation and ballooning degeneration of the hepatocytes or 
confluent hepatocyte necrosis in the liver 4,6.  
19 
 
PREGNANCY AND HEV  
Pregnant women, particularly those in 2nd and 3rd trimester of 
pregnancy are more frequently affected during hepatitis E outbreaks. 
They have a worse outcome than other form of viral hepatitis.  
It was proposed that severe fetal infections and fetal death may 
produce toxins that overload circulation which causes severe maternal 
disease27. During pregnancy there is increased sensitivity to hepatitis E 
virus mediated endotoxins1 called Schwartzman-like phenomenon. 
Hepatitis E virus infection are fatal as they precipitate pregnancy 
associated eclampsia with disseminated intravascular coagulation due to 
hepatic and renal failure 28. 
 Following are the two possible host factors that favor fulminant 
hepatic failure to occur in hepatitis E infected pregnant women: 
o Immunological changes  
o Hormonal changes during pregnancy 
IMMUNOLOGICAL CHANGES DURING PREGNANCY28  
During the early weeks of gestation up to 20thweeks, T cells are 
significantly reduced. It is a protective modulation of cell mediated 
immunity (CMI) to sustain the highly antigenic fetus and the placenta 
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during pregnancy. Placenta are resistant to cell mediated damage as they 
do not express MHC.  
They express a unique HLA-G molecule which inactivates Natural 
Killer cells by binding to its receptors CD16 and CD56. It also produces 
indoleamine 2, 3 dioxygenase enzyme, inactivate and deplete the 
aminoacid tryptophan, which supports T cell function and hence 
suppresses CMI. Increase in cytokines such as TGF-β, IL-4 and IL-10 
inhibits cell mediated immunity.  
HORMONAL FACTORS IN PREGNANCY 
Increased incidence of fulminant hepatic failure may be associated 
with hormonal changes. As the period of gestation progresses the 
hormones like estrogen, progesterone and human chorionic gonadotropin 
also increases. Estrogen causes shrinkage of thymus and deplete the 
number of CD4 and CD8 cells. Progesterone blocks T cell development 
i.e. they inhibit Th1 cells and promote Th2 cells by producing involution 
of thymus more effectively than estrogen. It was also shown that there is 
increased level of T helper2 cytokines assuming this may cause liver 
injury and have a role in increased severity of HEV infection in 
pregnancy25.  
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PROBABLE MECHANISM OF FULMINANT HEPATIC IN 
PREGNANCY19 
In addition to the above mentioned hormones, high levels of steroid 
hormones are also appreciated during pregnancy. Through NF-κB 
steroids mediate lymphocyte apoptosis and this physiological down 
regulation helps to retain the fetus. In studies it was shown that the 
activity of p65 component of NF-κB was decreased in peripheral blood 
mononuclear cells as well as liver biopsy of pregnant women who died of 
fulminant hepatic failure. It was established that absence of p65 is 
responsible for liver damage in fulminant hepatic failure associated in 
hepatitis E infected mothers.  
CLINICAL MANIFESTATION  
Incubation period ranges from 2 to 8 wks for the clinical 
manifestation of the disease. Wide spectrum of clinical manifestation 
have been observed, from self-limiting, subclinical, acute hepatitis to 
fulminant hepatitis in case of pregnant mothers but never proceeds to 
chronicity.  
It is most commonly seen in the age group of 15 to 45. It is mostly 
asymptomatic in children. 1% mortality in the general population is due 
to fulminant hepatic failure.  
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SIGNS AND SYMPTOMS 
PRE-ICTERIC OR FIRST PHASE 
Influenza like symptoms  
 Abdominal pain 
Tenderness  
 Nausea  
Vomiting 
 
ICTERIC OR SECOND PHASE 
 Jaundice  
 Dark urine 
 Viremia 
 Elevated liver enzymes 
 Antibody sero conversion 
 Clearing of the viruses 
First phase or pre-icteric phase lasts for 1 to 10 days followed by 
second or icteric phase persist for 15 to 40 days.  
OUTCOME OF HEV 
Typically hepatitis E virus infection is self-limiting without 
progression to the chronic illness. However hepatitis E infection is more 
23 
 
severe than hepatitis A. It causes fulminant hepatic failure in pregnant 
women and can be fatal. 
Fulminant form of hepatitis E infection occurs more frequently in 
the third trimester of pregnancy with a mortality rate of 25%.  
However, on the basis of clinical presentation hepatitis E cannot be 
differentiated from other forms of viral hepatitis. In fact, not all hepatitis 
E infections are clinically apparent. 
Increased frequency of abortion, neonatal deaths and still births are 
noted among pregnant mothers with hepatitis Einfection4  
Other complications are prolonged cholestatic hepatitis, acute HEV 
super infection in patients with cirrhosis, co-infection with other 
hepatotropic viruses and autochthonous hepatitis E virus in developed 
countries 
SEROEPIDEMIOLOGY  
Hepatitis E cause waterborne epidemic disease with peak clinical 
attack rate in young adults and high rate of fulminant hepatitis in 
pregnancy. The earliest recorded outbreak of HEV occurred in the year 
1955 in Delhi, India, following heavy flooding of the river Yamuna. 
Thereafter, many number of outbreaks and sporadic cases have been 
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documented in a wide variety of developing and tropical regions, together 
with India, Nepal, Pakistan, Myanmar, Indonesia, China, the central 
Asian region of the former Soviet Union, Ethiopia, Egypt, Algeria, 
Jordan, the Ivory Coast, Sudan, Chad, Somalia, Ethiopia, and Mexico4,5. 
HEV epidemiology in hyper endemic regions 
Epidemics  of  hepatitis  E  are  known  to  occur  frequently In  
hyper endemic  regions, typically  separated  by  a  few  years.  The 
outbreaks are regularly large, and affect several 100 to several 1000 
persons. They are often related to drinking of water contaminated with 
infected person’s feces. Their time-course varies from unimodal  
(few weeks) to prolonged, multipeaked (last for over a year) epidemics. 
The multipeaked represent continuous water contamination. The 
outbreaks normally follow heavy rainfall and floods. It create conditions 
that favor contamination of drinking water with human excreta, or during 
summer months, probably due to reduced water flow in rivers cause 
increased concentration of fecal pollutants. In Southeast Asia, repeated 
outbreaks have been shown to be related with disposal of human excreta 
into rivers, and people tend to use the same water for cooking, drinking, 
and personal hygiene. They favor constant fecal contamination of water. 
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Occurrences  of  hepatitis  E  have  happened  in  underdeveloped  
urban  areas  with  leaky water pipes passing through soil that is 
contaminated with sewage. During periods of erratic water supply, 
negative pressure forms in pipes of no flow which allow inward suction 
of contaminants into the pipes. Few outbreaks are associated with food-
borne transmission due to a relatively extended incubation period (up to 
10 wks)Genotype 1 of hepatitis E virus is the predominant cause of 
sporadic hepatitis and epidemics in hyperendemic regions. 
Sporadically occurring hepatitis in many of the regions have been 
serologically confirmed as hepatitis E virus infection. In fact, hepatitis E 
virus is one of the most common etiology of sporadic hepatitis in the 
endemic regions. 
 A salient feature of hepatitis E is that it has age specific clinical 
attack rate with its peak among young adults ranging from 15 to 40 years 
of age in developing countries1.Survey of sera collected from a  
hepatitis E endemic area of India over a period of ten years documented 
that most hepatitis A infection occurred before five years of age, whereas, 
hepatitis E virus infection occurred after sixteen years of age. However, 
all age groups are affected with male preponderance and mostly adults 
develop clinical evidence of hepatitis than children during epidemics2,3. 
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In most hepatitis E endemic areas, antibodies have been identified 
in 5% of children in the age group less than ten years when compared to 
10% to 40% in young adults >25 years of age4. A recent study from India 
have reported >60% of children <5 years of age have antibodies against 
hepatitis Evirus4. 
By Nargis et al, seroprevalence of anti-hepatitis E IgG in New 
Delhi, India is 33.67% in asymptomatic healthy mothers2. Whereas in 
Spain and Turkey prevalence it is 0.6-2 and 12.6 percent 
respectively2.Arankalle et al states a seroprevalence of23.62% of IgG in 
the general population is 2. By Khuroo et al, it is 5% in asymptomatic 
healthy children2. 
By Radhakrishnan et al, among 361 cases of acute viral hepatitis 
17.3%(66) were positive for IgM29. By Singh et al 40% of pregnant 
women were positive for IgM anti HEV antibody29. By Bista et al, out of 
19 jaundiced pregnant women 16 (84.2%) were positive for anti HEV 
IgM antibody29. 
Relatively high seroprevalence rate were reported in developed 
countries like Japan (4%-7%) and U.S (15%- 20% in blood donors)28. 
The urban sewage samples from non-endemic areas like Spain, Greece, 
France, Sweden, and U.S tested positive for hepatitis E virus infection28, 
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signifying that the healthy population of non-endemic areas may also be 
exposed to other types of animal HEV strains that do not develop any 
clinical manifestations.  
 The development of a sensitive serological assay has permitted the 
complete analysis of HEV seroprevalence and its distribution worldwide. 
Contrary to the expectations, the prevalence of anti HEV IgG is much 
lower in endemic regions and higher in non-endemic region.  
Molecular methodology to the epidemiology of hepatitis E virus 
hold some promise. The moderately low level of hepatitis Ein blood and 
feces restricts the practicality of hybridization without amplification. RT-
PCR has been useful for checking the outcomes of serological test and for 
assessing the duration of infectivity of the cases. Limitation to molecular 
epidemiological studies are due to fairly short duration of faecal shedding 
and viremia. Its main significance is identification of different types of 
hepatitis E virus genotypes and their association to specific epidemics and 
environmental locations. Furthermore, RT-PCR has been used to identify 
hepatitis E in sewage and contaminated water. 
RISK GROUP IN THE POPULATION7,16 
1. People living in areas where community outbreaks of hepatitis E 
infection occurs 
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2. People living in overcrowded refugee camps following disastrous 
events 
3. People travelling to hepatitis Eendemic areas 
4. People with chronic liver disease  
5. People handling pigs, cows, sheep, goat and non-human primates 
which may be infected with hepatitis E virus. 
6. Travelers to endemic areas 
DIAGNOSIS 
 Hepatitis E should be should be suspected in endemic areas during 
outbreaks of water-borne hepatitis in people living in sub optimal sanitary 
conditions. In developed nations hepatitis E should be suspected in 
patients presenting with signs and symptoms of hepatitis with history 
recently returned from endemic areas. Similar to the other forms of viral 
hepatitis, serological tests play an important role in establishing a 
definitive diagnosis of hepatitis E.  
Specific test for anti HEV IgM and IgG antibodies are available. 
IgM is the acute phase marker and IgG determines the exposure to HEV. 
Detection of IgM is up to 90% during acute infection if the suspected 
patient’s serum samples are collected between 1 and 4 weeks after the 
onset of symptoms. During the first 4 weeks of infection after the onset 
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on disease, IgM reaches peak titer of 1:1000 to 1:10000 and disappears 
within 3 months in 50% of the patients5. Between 2 and 4 weeks, IgG 
peaks in titer of 1:1000 to 1:100000 and thereafter diminishes rapidly 
relatively5. According to Clayson et al., in the infected people IgG 
antibodies against HEV persist for more than 14 years in 47% of the 
patients7. 
 
Fig 3.3: Diagnosis of HEV infection 
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IMMUNOLOGICAL DIAGNOSIS  
 ENZYME IMMUNO ASSAY (EIA)7 
 IMMUNOFLUORESCENCE MICROSCOPY (IFE) 
 Enzyme immune assay is a highly sensitive, inexpensive and a 
practical method for detection of antibodies against hepatitis E virus. 
IgM- acute phase marker 
IgG- measures exposure to hepatitis E 
Specific antibodies can be detected in either blood or serum. 
Following are the antigenic domains found in the ORF proteins 
1. ORF1 – 12 antigenic domains 
2. ORF2 – 6 antigenic domains 
3. ORF3 – 3 antigenic domains 
Complete ORF3 and a large segment of ORF2 or ORF3 C end 
domain and recombinant proteins originating from the ORF2 are used for 
detection of IgM and IgG antibodies of HEV. In the convalescent stage of 
the disease course, ‘capsid-like’ or large ORF2 particles are more 
effective in detection of anti HEV. 
Synthetic peptide antigens are used to confirm enzyme immune 
assay results and to exclude nonspecific reactions. Their use increase the 
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specificity of the reaction and helps to determine the genotype ofhepatitis 
E. Disadvantage of this peptide antigens is that it has low sensitivity and 
not reliable in detection of antibodies in the convalescent period7.  
4 short recombinant proteins derived from 3’ end of ORF-2 with 42 
amino acid and ORF-3 with 33 amino acid of Burmese (genotype –I ) and 
Mexican (genotype –II) are used by two Genelab EIA. 2 recombinant 
proteins obtained from the complete ORF3 with 123 amino acid of the 
Burmese genotype I strain is used by Abbott –EIA7. Sensitivity, 
specificity, positive predictive value and negative predictive values of all 
three combination of EIA’s are 100%, 99.5%, 75% and 100% 
respectively7. 
According to Mast et al, 12 different enzyme immune assay 
showed a concordance from 41 to 94 percent in blood donors and 0 to 
89% among reactive sera with mean 68 and 32 percent respectively7. 
During acute HEV infection inflammation of liver or damage to 
liver tissues can be assessed by elevated liver enzymes like glutamyl 
transpeptidase (GGT) alanine aminotransferase (ALT)  
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IMMUNOFLUORESCENCE MICROSCOPY (IFE) 
 This is a semi-quantitative test which measures the concentration 
of anti HEV antibodies against hepatitis E virus. Fluorescein–conjugated 
anti-HEV IgG to hepatitis E antigen in the liver tissue is blocked by anti 
HEV antibodies. 
IFE is expensive and laborious hence not useful for routine 
diagnosis.  
MOLECULAR DETECTION OF HEV 
IMMUNE ELECTRON MICROSCOPY 
NUCLEIC ACID AMPLIFICATION TEST 
VIRAL ISOLATION   
IMMUNE ELECTRON MICROSCOPY (IEM)17 
 Balayan et al., in 1983 used IEM to detect virus like particles in the 
clinical specimens. Antibodies to HEV derived from acute phase or 
convalescent phase sera, precipitate the HEV particles. By rating the 
antibody coating, concentration of the anti HEV antibody can be 
determined semi-quantitatively.  
 For routine analysis, immune electron microscope (IEM) is not 
suitable as its sensitivity and specificity of the assay is insufficient. 
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Moreover clinical samples contains less number of virus like particles 
(VLPs) to be detected by IEM.  
Molecular methods in diagnosis of hepatitis E have replaced 
Immune electron microscopy as it is positive in only 10% of cases5. 
NUCLEIC ACID AMPLIFICATION TEST 
They can be used to detect HEV RNA either in serum/blood or 
stool. These tests are of importance during the window period as the 
specific antibodies to HEV are not mounted to the detectable levels, 
hence the serological test are found to be negative3. 
Nested RT PCR and real time RT PCR are nucleic acid based 
techniques is the method of choice for the specific detection of HEV 
RNA in blood and faeces during the acute phase of infection. This 
method is very advantageous in detecting divergent hepatitis Evirus 
strains in non-endemic countries where some assay fail to detect 
serological response to hepatitis E. But the sensitivity of the test depends 
on a proper match between the hepatitis E virus strain and the PCR 
primers. 
 Conventional RT-PCR detects viral RNA, not only from sera and 
faeces in humans but also from clinical samples like bone marrow, 
34 
 
plasma, serum, salivary gland, mesenteric lymph nodes, inguinal lymph 
nodes, kidney, urine, liver and bile of domestic pigs and other animals 
like wild boar, sika deer, mongoose, chickens and also from contaminated 
water7. 
VIRAL ISOLATION17  
 For viral characterization and diagnosis, establishment of a 
practical cell culture that allow the multiplication of hepatitis Ein vitro is 
very critical. The use of human lung diploid cell culture system (2BS, 
PLC/PRF/5, A549,HepG2) and primary cell culture system from non-
human primates like chimpanzees, African green monkeys, cynomolgus 
macaques and tamarins have been reported7,17. 
But these cell culture medium cannot be used for virological and 
biophysical studies of hepatitis E because they do not provide high-tire of 
HEV in the culture medium and have reproducibility.  
Toshinori Tanaka et al used Faecal suspension with 2.0 x 10-7 of 
HEV copies ml-1 were used successfully in developing a cell culture 
system with an HEV titre of up to 108 in PLC/PRF/5 cells 17.  
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TREATMENT 
Treatment of hepatitis E virus is supportive and involves bed rest, 
adequate hydration and electrolyte repletion. Almost all patients are able 
to clear the virus spontaneously. There is no specific therapy available in 
altering the course of acute hepatitis E infection. Antivirals have not been 
effectively established for the treatment of hepatitis E infection. In acute 
severe form of infection, patients are treated with ribavirin for 21 days. 
Pilot studies in cell culture suggest that interferon alpha and ribavirin may 
inhibit hepatitis E virus1.Though ribavirin is contraindicated in pregnancy 
for its teratogenicity, the risk of untreated hepatitis E infected mother and 
fetus are essentially high.  
PREVENTION OF HEPATITIS E VIRUS  
Following are the most important means of prevention 
o Good personal hygiene 
o High quality public water supplies 
o Proper disposal of sanitary waste and 
o General food safety  
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Recommendation16:  
1. Disease surveillance and outbreak detection 
a. Enhance hepatitis Ediagnosis and reporting in all acute hepatitis 
cases particularly those that test negative for hepatitis A and hepatitis B 
virus to enable epidemiological investigation and out breaks 
b. Use of molecular methods to determine the different     genotype 
prevalence in an area. 
2. Food and water safety 
a. Increased awareness among food handlers  
b. Food surveillance programme for hepatitis E 
3. Public health education 
 a. Sea foods like shell fish, pork and pig offal should be cooked 
completely before consumption 
 b. To take appropriate measures to prevent hepatitis Einfection 
when travelling to an endemic areas   
4. Local study 
To monitor hepatitis Eprevalence and epidemiological changes 
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SWINE HEV  
 For the first time in the year 1997 by Meng et al, HEV from the 
clinical samples of pigs in USA was identified and demonstrated. 
Subsequently, other countries from all over the world with high 
production of pork, hepatitis E virus strains have been detected. These 
hepatitis E genotypes showed their association with genotype III and 
genotype IV. Swine HEV strain is almost homologous with the human 
hepatitis E from the same geographic location(Hsieh et al, Pina et al, 
Wang et al, Huang et al, Yazaki et al)7,.The swine hepatitis E virus shared  
more than 97% amino acid identity with human hepatitis E genotype III16. 
Isolates of hepatitis E virus strains from Thailand and Mexico have been 
classified as genotype III where human isolates of hepatitis E has been 
categorized as genotype I and II. In India human HEV strains are 
designated as genotype I and swine as genotype IV7. 
AVIAN HEV 
 In U.S., Haqshenas et al chicken isolated a novel HEV strain, the 
avian HEV from the bile sample of chicken suffering from Hepatitis-
splenomegaly syndrome 7. Comparison of avian HEV and BSLV(big 
liver and spleen disease virus) revealed resemblance of about 80%. 
Sequenced genome segment of isolates of avian HEV showed 50 to 60 
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percent similarity with human and swine HEV strains7. Variation in the 
position of ORF was observed, ORF 3 does not shown overlapping with 
ORF-1 unlike classical hepatitis E viral genome. According to Wang et 
al, and Haqshenas et al, it is not clear that whether isolates of avian HEV 
is a different genotype V of hepatitis E or it is another member of 
Herpevirus genus7. Later, phylogenetic analysis and sequence comparison 
of avian HEV discovered that it is most divergent of the hepatitis E virus 
strains and had 50% sequence identity28. Newly, another new avirulent 
strain of avian HEV was isolated from seemingly healthy chickens. It is 
assumed that the 2 avian HEV strains fit into presumed genotype V28. 
ANIMAL EXPERIMENTS 
Several species of monkey and chimpanzees are susceptible to 
hepatitis E virus infection. Most of our understanding of the pathogenesis 
of hepatitis E infection is derived from the reliable non- human 
experimental animal models like rhesus, cynomolgus macaques, owl 
monkeys and tamarins. 
Incubation period was 21 days after intraven 
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ous inoculation of Hepatitis E virus into cynamolgus macaques. 
During the initial highly replicative cycle, expression of HEV Ag appears 
approximately 7th day post infection4,6. During 2nd or 3rd week after 
inoculation, HEV Ag has been detected in faeces, bile and hepatocyte 
cytoplasm due to excretion of HEV into bile.  
Antigenic expression of hepatitis E covers approximately 
70%to90% of the hepatocytes and the quantity of viral antigen declines 
with the onset of raise in liver enzymes and there was faecal excretion of 
virus and viremia in the blood. Detectable antibodies to hepatitis E virus 
appears just before the elevation of ALT(alanine aminotransferase) and 
coincides with resolution of fecal virus shedding, viraemia in the blood 
and reduction in the viral antigen in the liver and correspond to the 
presence of histopathogical changes in the liver. In the last decade, a 
growing trend of hepatitis E notification has been observed. From 2001 to 
2010, the yearly notification of hepatitis E infection in the past decade 
has ranged from 26 to 117.In fact, hepatitis E turn out to be the most 
common cause of viral hepatitis reported in 2010. Hepatitis E  accounts  
for  44.3%  of  all  viral hepatitis  cases,  followed  by  27.7% of viral  
hepatitis  B  and  24.2%  of viral  hepatitis  A  
 India is endemic for hepatitis E infection and it is the most 
common cause of viral hepatitis in pregnancy with high mortality during 
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3rd trimester following fulminant hepatic failure which may be associated 
with the hormonal changes during the course of pregnancy22.Hepatitis E 
virus gives a large global burden of sporadic and epidemic hepatitis.  
HEV IN INDIA: 
Table: 3.1 Studies on HEV in India 
Study Location Population No. of patients 
Prevalence 
of 
antibodies 
Comments 
Naik et al, 1992 Kanpur, UP Outbreak Population 79000 - 
Municipal water was 
the source of 
contamination 
Nayak et al 
1989 South India 
Outbreak 
population 
(NP women 
and adult 
men) 
526 81.6% 0.06% CFR 
Malathi et al 
1995-96 Madras Children 127 15.7% - 
Madan et al, 1998 North India Sporadic 50 64.7 - 
Radhakrishnan 
et al 2000 South India 
Patients 
attending 
hospital 
381 17.3 - 
Jaiswal, 2001  Central India 
273 
(127P 
and 
146NP) 
57.5(P) 
46 (NP) 
Highest mortality in 
pregnant women in 
3rd trimester (56%) 
Beniwal, 2003 North India 3
rd
 trimester 
women 
97 47.4% Mortality rate 18% 
Singh et al, 2003 North India Pregnant 
women 
60 37% 
72% in 3rd trimester, 
64% mortality in 
pregnancy 
Khuroo 2003 Kashmir ALF patients 180 44% 95.8% pregnant 
women had ALF 
Mishra 2003 Bangalore Hospital patients 569 18% CFR 3.75% 
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Naik et al (2002) published the data regarding a large outbreak of 
hepatitis E occurred in Kanpur, Uttar Pradesh during 1991. The outbreak 
was related to contamination of the city’s municipal water supply system. 
Based on a sample survey, it was estimated that nearly 79,000 persons 
were affected. The attack rate was the highest in young adults, and was 
higher among males. The number of deaths recorded was 48; of this 13 
were among pregnant women. 
Nayak et al I n 1989 studied 169 pregnant women, 70 non-pregnant 
women and 287 adult men with  hepatitis and found that NANB hepatitis 
accounted for 81.6%, 48.6% and 57.1% of cases in the three  groups, 
respectively. 
Between February 1995 to January 1996, children with acute viral 
hepatitis (n=127) were studied in Madras in southern part of India. HEV 
was the sole infectious cause in 15.7% cases; in addition, 13.4% of cases 
had HAV and HEV co infection, and 0.8% had HAV, HBV and HEV 
coinfection. 
In another study from northern India by [Madan, 1998], role of 
HEV infection in causation of sporadic AVH (n=34) and FHF (n=16) was 
studied. Evidence of HE [Madan, 1998] infection was found in22 
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(64.7%) and 8 (50%) cases, respectively. It was the sole cause in 15/34 
(44%) cases with AVH and 7/16 (43.7%) cases with FHF.  
Prevalence of HEV infection was studied in 381 patients with acute 
hepatitis attending a hospital in southern India. HEV IgM was detected in 
66 (17.3%) patients. Most of those with hepatitis E were older children 
and adults; only 5.5% of these were children < 12 years of age 
[Radhakrishnan, 2000]. 
A study conducted in central part of India comprising 273 women 
with viral hepatitis (age 18-23 years) included 127 pregnant (AVH 83, 
FHF 44) and 146 non-pregnant (AVH 129, FHF 17) women. Of the 
pregnant women, 73 (57.5%) had HEV infection;of these, 42 had FHF. 
Among non-pregnant women, 67 (46% had HEV infection; of these, 2 
had FHF. HEV-infected women with FHF during third trimester of 
pregnancy had the highest mortality rate (56%) [Jaiswal, 2001]. 
In a study on 97 consecutive  pregnant women in third trimester 
with acute viral hepatitis (AVH) or FHF, HEV was  the leading cause in 
47.4% of cases, including 36.2% of those with uncomplicated AVH and 
75% of those with FHF .Twenty-four women died, including 18 with 
HEV infection [Beniwal, 2003]. 
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Of 60 pregnant women with acute hepatitis tested during the years 
1997 and 1998 in Delhi at AIIMS, 22 (37%) had detectable IgM anti-
HEV. Of the latter, 16 (72%) were in third trimester of pregnancy. 
Fourteen of the 22 (64%) HEV-infected pregnant women had FHF and all 
died [Singh, 2003]. 
During April 1989 to April 1996, 180 persons [69 male, 111 
female; age: mean ± SD [31.1 ± 14.7 years] with acute liver failure in 
Kashmir were studied. HEV was the cause in 79 (43.9%) patients. The 
study included 49 pregnant women; of them, 47 (95.8%) had HEV 
infection [Khuroo, 2003]. 
In another study done in bangalore by Mishra et al, 569 patients 
with hepatitis admitted to a hospital during1997-2000 were evaluated for 
IgM anti-HEV. Of these, 107 (72 male, 35 female) tested positive. The 
case-fatality rate was 3.75% (4/107). The highest hepatitis E rate was in 
the age group of 21-40 years. 
In a study conducted in Delhi by Patra et al among 220 pregnant 
women with acute viral hepatitis, 60% of cases were due to Hep.E. There 
was  higher rates of occurrence of FHF and of death in Women with 
hepatitis E than those in patients with hepatitis due to other causes. 
 
  
 
MATERIALS  
AND  
METHODS 
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MATERIALS AND METHODS 
TYPE OF STUDY:  
CROSS- SECTIONAL STUDY 
STUDY PLACE: 
 This study was done in the Department of Obstetrics and 
Gynecology, RSRM, Stanley Medical College and Hospital in association 
with Department of Microbiology, and Medical Gastroenterology, 
Stanley Medical College and Hospital, Chennai.  
PERIOD OF STUDY:  
May 2015 – Sept 2015 
SAMPLE SIZE:  
200   
Inclusion criteria 
All the asymptomatic pregnant mothers age > 18 yrs who were 
attending the antenatal OPD and who were willing to provide written 
informed consent were recruited for the study. 
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Exclusion criteria: 
• Alcohol intake 
• Chronic drug intake 
• Past history of jaundice 
• Chronic medical comorbidities 
Those who are not willing to give consent to participate in the study. 
PATIENT SELECTION:  
The study was conducted among the asymptomatic pregnant 
mothers attending routine antenatal checkup in theDepartment of 
Obstetrics and Gynecology, RSRM at Government Stanley Medical 
College and Hospital, Chennai for a period of  5 months from MAY 2015 
to Sept 2015.  
Population group were from in and around Chennai. 
The study was explained in detail to the pregnant mothers in their 
local language and informed consent were obtained.  
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All asymptomatic antenatal mothers Age >18 yrswho were willing 
to give informed consent irrespective of their gestational age were 
enrolled in the study.  
No samples were repeated from the same patients.  
200 asymptomatic pregnant mothers were selectedfor this study. 
Blood samples were collected and serum was separated from them 
to detect the presence of IgM and IgG antibodies to HEV and to detect 
viral RNA by PCR. 
Ethical consideration:  
 Ethical and research clearance was obtained from the ethical 
committee Stanley Medical College and Hospital. Permission to conduct 
the study was sought from the respective hospital authorities. Informed 
consent was obtained in the local language of the patientbefore enrolment 
into the study. 
Statistical analysis: 
 The collected data was analyzed with Stata 12 version. To describe 
about the data descriptive statistics frequency analysis, percentage 
analysis, cross tabulation were used for categorical variables and the 
mean and S.D were used. To find the significance in categorical data Chi-
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Square test was used. In all the above statistical tools the probability 
value .05 was considered as significant level.  
Data collection:  
Details were obtained directly from the patients with the help of a 
questionnaire which dealt with information regarding socio demographic 
data such as age, residential address, educational status, profession, 
socioeconomic status, source of drinking water and type of toilet facility 
to analyze various factors that contribute for the prevalence of HEV 
infection in pregnant mothers in the particular geographic area.  
Sample collection: 
Under aseptic precaution around 5 ml of blood sample was 
collected from each patients by venipuncture at the cubital fossa, by using 
23G needle. Blood was dispensed into a sterile test tube without 
anticoagulant. Samples were transported to the Microbiology lab. Each 
blood sample was allowed to clot and retract. Serum sample was 
separated from the clot as early as possible by centrifugation at 2500 rpm 
for five minutes to avoid hemolysis of the red blood cells. Samples were 
duplicated and safely stored into 2 mL cryovials containing 50µl of 
EDTA at -80°C deep freezer until tested.  
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These set of serum samples were used for doing indirect ELISA 
(Enzyme Linked Immunosorbent Assay) to detect both IgG and IgM 
antibodies against Hepatitis E virus.  
ELISA (Enzyme Linked Immunosorbant Assay) 
ELISA was done with a commercial kit (Composed of 12 antigenic 
regions derived from ORF2 and ORF 3) 
1. DSI-EIA-ANTI-HEV-IgM-KIT  
2. DSI-EIA-ANTI-HEV-IgG-KIT 
This test was intended for the screening of serum IgM and IgG 
antibodies against HEV. The test was performed according to the 
instructions provided in the kit literature. 
PRINCIPLE OF THE TEST: 
 The microtitre test wells were coated with HEV antigens. Diluted 
patients serum was into their designated wells. If specific antibodies to 
the antigen are present in the patient serum, they get bind to each other in 
the wells during the incubation period. When the test wells are washed 
unbound antibodies are removed. Microtitre plate was tapped over tissue 
paper to get rid of the excess washing solution or bubbles in the plate 
formed during the washing procedure.  
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To this microtitre plate, freshly prepared enzyme conjugate was 
added to all the plates including PC and NC. If the antigen antibody 
complex had formed in the well during the first incubation, enzyme 
conjugate will specifically binds to it. Again second set of washing was 
repeated and to this a chromogen substrate was added. The peroxidase 
enzyme present in substrate will catalyse the reaction that consumes 
peroxide and turns the chromogen from clear to blue. Addition of stop 
solution end the reaction and turns the blue colour to a bright yellow 
colour. The reaction can be read with an ELISA reader.  
MATERIALS AND EQUIPMENTS REQUIRED  
1. Purified water 
2. Pipettes to measure and dispense 10, 50, 90, 100 
3. Pipette tips 
4. Incubator at 37.0±1.0 C 
5. Automated microplate washer 
6. Microplate reader equipped with 450nm  
7. Disposable gloves 
REAGENTS 
1. 96 microtitre wells coated with HEV antigens 
2. Wash buffer 
50 
 
3. Sample diluent 
4. Enzyme conjugate and diluent 
5. TMB substrate and substrate buffer 
6. Stop solution 
7. Positive control (inactivated) 
8. Negative control(inactivated) 
HANDLING OF SPECIMENS 
 Plasma stored at -80°C was thawed for few minutes at 40°C to 
avoid fibrin precipitation. 
AUTOMATIC MICROPLATE WASHER: 
Washer was set up appropriately i.e. 380-400µl working washing 
solution into each wells and soak time at least 40 seconds and aspirate.  
PREPARATION OF THE REAGENTS 
HEV –Ag COATED STRIPS 
 The foil bag was opened and the strips were removed and placed in 
the microtitre plate. The strips were numbered and the wells were 
assigned with the respective samples with the help of a data sheet. Before 
initiating the assay all the strips were washed 2 times with the automatic 
microplate washer, as instructed in the manual. 
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PREPARATION OF WASH BUFFFER 
To 50ml of washing buffer (concentrated 25 fold), 1200mlof 
distilled water (1:25 ratio), was added and mixed thoroughly according to 
the manual. 
Note: the prepared working solution is stable for 14 days at  
18-24°C or for 28 days when used in GLP condition. 
PREPARATION OF THE WORKING CONJUGATE 
Working conjugate was prepared just before the test procedure. To 
0.65ml of conjugate (concentrated 21 fold), 13ml of conjugate diluent 
(1:20 ratio)was added and thoroughly mixed until diluted avoiding 
foaming. Intensive mixing was avoided.   
Note: it can be stored for 12 hours in the dark at 18-24°C 
PREPARATION OF THE SUBSTRATE MIXTURE 
 The substrate mixture was prepared just before use. To 0.65ml of 
TMB (concentrated 21 fold), 13ml of substrate buffer (1:20 ratio) was 
added and mixed thoroughly until diluted.  
Note: substrate mixture is stable for 10 hours when stored in a dark 
place at 18-24°C in a clean vial  
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DS-EIA-ANTI-M ASSAY PROCEDURE:  
ACCORDING TO THE MANUFACTURERS INSTRUCTIONS 
BEFORE ASSAY  
The coated strips was washed with working washing solution 2 
times before the procedure. 380-400µ of working washing solution was 
added into each well during washing. Soak time at least 40 sec was kept. 
Automated microplate washer was used after appropriate set up. The 
microtitre plate was tapped over tissue paper and was made sure that no 
fluid or bubbles are left inside the wells as they may adversely affect the 
assay precision. Data sheet are made ready for the controls and for the 
samples.  
1. 100µl of PC into one well and NC in 2 wells are added to their 
designated wells.  
2. 90µl of sample diluent and 10µl of test serum are added in rest of 
the wells. 
3. The plate was covered by a lid protective film. 
4. The plate was incubate for 30 minutes at 37±1°C in the incubator.  
5. The contents was removed by washing the plate for 4 times as 
described above. 
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6. 100µl of freshly prepared working solution of conjugate was then 
added into each wells. 
7. Step 4 & 5 was repeated. 
8. 100µl of freshly prepared substrate mixture was added into each 
wells. 
9. The plate was kept in a dark place for 20 minutes at 18-24°C 
10. 150µl of stopping reagent are added to all the reacting wells.  
11. Optical density at 450/620 nm using microplate reader was used to 
read the result immediately after adding stop solution. 
For the assay to be valid: 
PC > 0.6 and NC < 0.2 
CUT – OFF = AVERAGE OF NC + 0.200(coefficient – defined by 
manufacturer during statistical processing for each lot) 
INTERPRETATION OF RESULTS 
Sample is NEGATIVE if OD < CUT – OFF 
Sample is POSITIVE if OD ≥ CUT - OFF 
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PREPARATION OF THE REAGENTS FOR IgG ANTI HEV 
HEV –Ag COATED STRIPS 
 The foil bag was opened and the strips were removed and placed in 
the microtitre plate. The strips were numbered and the wells were 
assigned with the respective samples with the help of a data sheet. Before 
initiating the assay all the strips were washed 2 times with the automatic 
microplate washer, as instructed in the manual. 
PREPARATION OF WASH BUFFFER 
To 50ml of washing buffer(concentrated 25 fold), 1200ml of 
distilled water (1:25 ratio), was added and mixed thoroughly according to 
the manual. 
Note: the prepared working solution is stable for 14 days at 18-
24°C or for 28 days when used in GLP condition. 
PREPARATION OF THE WORKING CONJUGATE 
Working conjugate was prepared just before the test procedure. To 
0.65ml of conjugate (concentrated 21 fold), 13ml of conjugate diluent 
(1:20 ratio) was added and thoroughly mixed until diluted avoiding 
foaming. Intensive mixing was avoided.   
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Note: it can be stored for 12 hours in the dark at 18-24°C 
PREPARATION OF THE SUBSTRATE MIXTURE 
 The substrate mixture was prepared just before use. To 0.65ml of 
TMB (concentrated 21 fold), 13ml of substrate buffer (1:20 ratio) was 
added and mixed thoroughly until diluted.  
Note: substrate mixture is stable for 10 hours when stored in a dark 
place at 18-24°C in a clean vial   
DS-EIA-ANTI-G ASSAY PROCEDURE:  
ACCORDING TO THE MANUFACTURERS INSTRUCTIONS 
BEFORE ASSAY 
The coated strips was washed with working washing solution 2 
times before the procedure. 380-400µl of working washing solution was 
added into each well during washing. Soak time at least 40 sec was kept. 
Automated microplate washer was used after appropriate set up. The 
microtitre plate was tapped over tissue paper and was made sure that no 
fluid or bubbles are left inside the wells as they may adversely affect the 
assay precision. Data sheet are made ready for the controls and for the 
samples. 
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1. 100µl of PC and NC in duplicates are added to their designated 
wells.  
2. 90µl of sample diluent and 10µl of test serum are added in rest of 
the wells. 
3. The plate was covered by a lid protective film. 
4. The plate was incubate for 30 minutes at 37±1°C in the incubator.  
5. The contentswas removed by washing the plate for 4 times as 
described above. 
6. 100µl of freshly prepared working solution of conjugate was then 
added into each wells. 
7. Step 4 & 5 was repeated. 
8. 100µl of freshly prepared substrate mixture was added into each 
wells. 
9. The plate was kept in a dark place for 20 minutes at 18-24°C. 
10. 50µl of stopping reagent are added to all the reacting wells. 
11. Optical density at 450/620 nm using microplate reader was used to 
read the result immediately after adding stop solution. 
For the assay to be valid: 
PC > 0.6 and NC < 0.2 
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CUT – OFF = AVERAGE OF NC + 0.200(coefficient – defined by 
manufacturer during statistical processing for each lot) 
INTERPRETATION OF RESULTS 
Sample is NEGATIVE if OD < CUT – OFF 
Sample is POSITIVE if OD ≥ CUT – OFF 
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OBSERVATION AND RESULTS 
Two hundred asymptomatic pregnant women attending routine 
antenatal clinic in a tertiary care hospital, were included in the study. 
Blood samples were collected and serum was separated by centrifuging at 
2500 rpm. All the serum samples were stored to detect IgM, IgG 
antibodies against hepatitis E virus from May 2015 to September 2015. 
Our observations are as follows: 
The mean age group of the pregnant women was 24.12 ± 3.64. 
Among the 200 women 82.2 % fell under 21-30 years of age as described 
in Fig 5.1 
 
Fig 5.1: Age distribution of the study group 
13%
82%
5%
Age distribution of the study group  n=200
<20 y 21-30 >30
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Among the women whom we studied, majority(49%) fell in the 
second or third trimester (39%) as in fig 5.2 
 
Fig 5.2: Distribution of the study women in different trimesters 
There was equal representation primi and multigravida as depicted 
by fig 5.3 
 
Fig 5.3: Gravid status of the study group 
12%
39%
49%
Distribution among trimesters  n=200
1st 2nd 3rd
55%
45%
Gravid state of the study group  n=200
primi multi
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Majority of the members of the study group have completed higher 
secondary education as shown in fig 5.4 
 
Fig 5.4: Educational status of the study group 
Majority of the pregnant women were from upper lower(57%) 
followed by lower middle (29%) as explained by fig 5.5 
 
Fig 5.5: Socio-economic status of the study group 
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Majority of the population has been using Metro water (61.5%) as 
the source of drinking water, the rest using borewell and can water as 
shown in fig 5.6 and 24.5% have been boiling the water before use. 
 
Fig 5.6: Source of water of the study group 
24.5% of the pregnant women did not have adequate drainage 
facilities at home as shown in fig 5.7 
 
Fig: Drainage facilities at home of the study group 
61%14%
25%
Source of water of the study group n=200
metro water borewell water purified can water
81%
19%
Drainage facilities at the home of the pregnant women 
n=200
Yes No
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About 79.5 % responded positively when questioned about the 
habit of had washing before food and after using toilet and 45.5 % of 
women consumed non vegetarian food as depicted by fig 5.8, 5.9 
respectively. 
 
Fig 5.8 Habit of hand washing at the home of the pregnant women 
 
Fig 5.9: Drainage facilities at the home of the pregnant women 
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The results of Ig M and Ig G ELISA were analyzed with respect to 
the possible risk factors if HEV disease. 
ELISA for Ig M was positive in 9 patients all within the age group 
of 21-30 y of age. Of the 9 positive women, 4 were primigravidae and 5 
were multi-gravidae. These patients were equally distributed in all the 
three trimesters. 7 of these patients were consuming non vegetarian food 
which reached statistical significance (p=0.04) and 8 patients who tested 
positive to Ig M ELISA did not wash their hands before food and after 
using toilet (p<0.05). 6 patients were using metro water for drinking 
(p=0.94) and 7 of them did not boil the water before drinking (p<0.05). 
While we analyzed the sanitary facilities and Ig M positivity, we found 
that seven of the 9 positive patients did not have adequate drainage 
facilities at home (p < 0.05). Majority of the patients who turned positive 
were illiterates (p<0.05) and 5 were belonging to the upper lower class of 
modified Kuppusamy socio economic status scale 2015(p<0.05) and the 
results are depicted in fig 5.10-5.13 
ELISA for Ig G was positive in 13 patients and majority within the 
age group of 21-30 y of age. Of the 9 positive women, 7 were 
primigravidae and 6 were multi-gravidae. Majority of the sero positivity 
occurred in 3rd trimester (p=0.05). 9 of these patients were consuming non 
vegetarian food which reached statistical significance (p=0.07) and 9 
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patients who tested positive to Ig G ELISA did not wash their hands 
before food and after using toilet (p<0.05). 8 patients were using metro 
water for drinking (p < 0.05) and 10 of them did not boil the water before 
drinking (p<0.05). While we analyzed the sanitary facilities and Ig M 
positivity, we found that six of the 13 positive patients did not have 
adequate drainage facilities at home (p =0.06). Educational status did not 
differ within the positive population (p=0.90) and 6 were belonging to the 
upper lower class of modified Kuppusamy socio economic status scale 
2015(p<0.05) and the results are depicted in fig 5.14-5.16 
 
Fig 5.10: Ig M seropositivity and dietary habits 
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Fig 5.11: Ig M sero-positivity and habit of hand washing 
 
 
Fig 5.12: IgM sero-positivity and habit of boiling  
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Fig: 5.13: Ig M sero-positivity and 2015 modified  
Kuppusamy’s socio-economic status scale. 
 
 
Fig 5.14: Ig G sero-positivity and habit of hand washing 
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Fig 5.15: Ig M sero-positivity and habit of boiling  
water before drinking 
 
Fig 5.16: Ig G sero-positivity and 2015 modified Kuppusamy’s  
socio-economic status scale 
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DISCUSSION 
Enzyme Linked Immunosorbent Assay (ELISA) is the serological 
test available for antibody detection of both anti HEV IgM and IgG of 
hepatitis E virus infection. It is highly sensitive, inexpensive and a 
practical method for detection of HEV antibodies. 
The population included in this study were asymptomatic pregnant 
women who comes for routine antenatal checkup in a tertiary care 
hospital. All patients were from different areas in and around Chennai.  
Sera of all the enrolled patients were analyzed for the presence of 
anti-HEV IgM and IgG antibody against hepatitis E virus by a 
commercially available Enzyme Linked Immunosorbent Assay  
(DSI - EIA - ANTI - HEV - M; DSI - EIA - ANTI - HEV - G) 
ANALYSIS OF HEV SEROPOSITIVITY 
 We found totally 4.5% (9/200) IgM and 6.5% (13/200) IgGsero 
prevalence in asymptomatic pregnant women. Concerning the Sero 
prevalence of hepatitis E virus infection in asymptomatic pregnant 
women, results of this study were similar to 5.62% sero prevalence of 
IgG a report given by Daniel et al (2004) at Vellore from 600 samples 
including blood donors, antenatal mothers and from pre-operative 
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patience. And also coincides with other studies from south India with 8% 
anti HEV seropositivity2.  
 
Fig 6.1: % prevalence of anti IgG HEV in various studies 
And other studies from Pune and Lucknow documented a much 
higher prevalence in adult population (40%-50%). But the seroprevalence 
of this study is also comparable to the 3.6% seroprevalence of hepatitis E 
in pregnant women in Madrid, Spain and 6.6% seroprevalence of IgG 
antibodies to HEV reported in pregnant women infected with HIV in 
Gabon and central Africa55.  
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70 
 
Table 6.1 % prevalence of anti IgG HEV in various studies in India 
Author Year Place 
Sample 
size 
Prevalence Population 
Khuroo et al 1994 Kashmir 40 5% 
Asymptomatic 
healthy children 
Arankalle et al 1995 Pune 1602 23.62% 
Healthy general 
population 
Aggarwaal et al 1997 Lucknow 95 59.25% 
Healthy general 
population 
Das et al 2000 
New 
Delhi 
500 35.6% 
General 
population 
sporadic AVH 
Mathur et al 2001 
New 
Delhi 
2070 26.25% 
Children with mild 
non-hepatic illness 
Mohanavalli et al 2003 Chennai 185 9.5% Healthy children 
Daniel et al 2004 Vellore 600 5.62% 
Blood donors and 
pregnant women 
Nargis et al 2009 New delhi 300 33.67 
Asymptomatic 
pregnant women 
Our study 2015 Chennai 200 6.5% 
Asymptomatic 
pregnant women 
AGE DISTRIBUTION 
The study group included in asymptomatic pregnant mothers 
wereaged 18-35 years with the mean age of 24.12years. According to the 
study carried out by Shams et al, out of 65 pregnant women, the mean age 
71 
 
was 25 years60. Nargis Begum et al mean age of the 300 asymptomatic 
primigravida were 21.92 ± 2.66 years (range 18-35)2.  
All cases of IgM HEV and majority of Ig G sero-prevalence were 
reported in the age between 21 and 30 years and this might be attributed 
to the predominant population group that has been studied. 
Table 6.2 HEV and Mean Age 
Study Population studied Mean age Comments 
Nargis et al 
Asymtomatic 
pregnant women 
21.92 ± 2.66 
 
Both falls within the 
age of 21-30 years Our study 
Asymtomatic 
pregnant women 
24.12 ± 3.64 
GRAVIDA 
Among 200 asymptomatic pregnant patients, 55% were 
primigravida, 45% of them were multigravida. Compared to 
primigravida, 2nd and multi gravida were less in number. Most of them 
were in their second and third trimester of pregnancy. According to 
Nargis Begum et al mean period of gestation was 19.06 ±2.25 wk with a 
range of 16-24 wk2. 
Seropositivity of pregnant women of different gravidawere equally 
distributed in different gravida. This result was in contrast to the study 
done by Cosme et al, where seropositivity of hepatitis E were in 
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association with number of pregnancy though the reason was not yet 
clear55. 
EDUCATIONAL STATUS 
Out of 200 asymptomatic pregnant women 7% of them were 
illiterates Majority of them have studied up to higher secondary school. 
Diploma holders among asymptomatic pregnant women was only 10%. 
Though IgG positivity was common in illiterates, IgGsero-
prevalence did not differ much by the difference in educational status. 
This study results were similar according to Cosme et al observation, in 
which he states that there was no positive association with the education 
status and HEV seropositivity55. But the results were contrary to the study 
done by Sekan et al, according to which education seems to be the only 
risk factor for HEV seroprevalence18,58. 
Table 6.3 HEV and Educational Status 
Study Population 
Percentage of 
illiterates with 
positive IgG 
Comments 
 
Nargis et al Asymptomatic Pregnant women 80.6 
 
Lower Ig G positives in 
illiterates than the above 
study 
But did not decrease 
with increasing level of 
education (p=0.90) 
Our study Asymptomatic Pregnant women 44.4 
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SOCIOECONOMIC STATUS 
According to the Kuppusamy’s criteria, about 5%, 57%, 29% and 
9% were in the lower, upper lower, lower middle and upper middle class 
of socioeconomic status respectively. Majority of them were in the upper 
lower class. Clubbing patients with upper lower and lower, there were 
33% of women from lower socio-economic status and sero-positivity of  
IgG and Ig M were significantly more positive than in the higher groups 
(p<0.05). The results are similar to the study conducted by Nargis et al. 
No seropositive cases were seen in the lower group of 
socioeconomic status. And this cannot be always true because out of 200 
pregnant women only 5% of them were in the lower level of 
socioeconomic status in the study population. According to Nargis et al 
socioeconomic status appeared to be the risk factor for IgG sero 
prevalence. 
Study Population 
Percentage of women 
with lower socio-
economic status & 
positive IgG 
Comments 
 
 
Nargis et al 
Asymptomatic 
Pregnant women 
48.5 
Similar increase in 
positivity with 
declining socio-
economic status 
Our study 
Asymptomatic 
Pregnant women 
33 
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FOOD HABIT AND USE OF BOILED WATER  
Out of 200 asymptomatic pregnant women 54% of the pregnant 
women were following non-vegetarian diet whereas only 46% of them 
were vegetarian.  
24.5% of the pregnant women were using boiled water whereas 
majority ie., 75.5% of them used water without boiling. These results 
were in contrast to Cosmo Alvarado et al where the above risk factors 
were not associated with sero-positivity. 
 Majority of sero-positive patients were consuming non-vegetarian 
diet which shows that the asymptomatic pregnant women following Non-
vegetarian dietary habit were predominantly associated with HEV 
seroprevalence. This high prevalence may be due to consumption of 
undercooked meat. According to Rakesh et al HEV-RNA has been 
detected from domestic swine in their faeces and also HEV antibodies 
have been detected in the sera of cattle, sheep, pigs and rodents4.  
Most of the HEV positive pregnant women i.e., were not using 
boiled water for drinking. This shows, it may be related to HEV positivity 
as boiling can inactivate HEV5. 
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But from the above result, no positive association was found 
between source of drinking water and use of boiled water with HEV 
positivity. Similar observation was documented by Cosmeet al55 and also 
agrees with results found in other studies18. 
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SUMMARY 
Asymptomatic pregnant women attending routine antenatal check 
up in a tertiary care hospital were enrolled and the observational study 
was conducted between “May 2015 and September 2015”. Total of 200 
pregnant mothers were selected and evaluated by a questionnaire which 
dealt with information regarding socio demographic data such as age, 
residential address, educational status, profession, socioeconomic status, 
source of drinking water and type of toilet facility. Serum samples were 
collected and serological test was done using ELISA to detect anti-HEV 
IgM and IgG antibodies and were done according to the manufacturer’s 
instruction. 
In the present study, out of 200 asymptomatic pregnant women 
majority of them were seen in the age group of 21-30 (mean age 24.15). 
Most of them were in the 2nd and 3rd trimester of pregnancy. 
Primigravidae outnumbered multi gravida. Educational status of most of 
the pregnant women was till higher secondary school. Graduates and 
illiterates were almost  in equal percentage. Most of the pregnant mothers 
belong to upper lower class.  
In this study we found totally 4.5% of IgM and 6.5% of IgG sero 
prevalence in asymptomatic pregnant women. Most of the positive cases 
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were in the age group 21-30. Sero prevalence was highly associated with 
women not having a habit of hand washing, not having adequate drainage 
facilities, who are consuming non vegetarian diet, poor socio-economic 
status. Analysis of anti HEV sero prevalence with age, gravida, 
educational level, however revealed no significant association. Our study 
was in contrast to the results of Cosme et al with respect to hand washing, 
educational level, socio-economic status, consumption of untreated water 
and undercooked meat. Our study had similarities with respect to age, 
socio-economic status and in contrast with respect to educational status, 
non-vegetarian diet, hand washing, boiling of water as studied by 
Nargiset al2.  
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CONCLUSION 
1) In India many factors are favorable for the transmission of the disease 
like low socioeconomic status, poor hygiene and low level of 
education.  
2) The seroepidemiology of hepatitis E virus infection in pregnant 
women is largely unknown in different states in India.  
3) Thus it is desirable to determine the magnitude of hepatitis E virus 
seroprevalence in pregnant women so as to consider HEV as one of 
the public health problem and also for the ideal planning of preventive 
measures against hepatitis E infectionin our area. 
4) From the present study we conclude that there is very low prevalence 
of anti HEV IgM and IgG antibodies among asymptomatic pregnant 
women when compared with study results of north India.  
5) Further studies with more numbers and improvement in the molecular 
testing will be an important research protocol. 
6) Role of HEV vaccination is currently questionable in India at present 
may throw better insights into the HEV epidemiology. 
7) Improved sanitation, boiling water for drinking, safe washing practices 
will go a long way in the eradication of this subclinical infection 
which can be deadly during the later trimester of pregnancy.  
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ANNEXURES 
  
PROFORMA 
                                                                                                                            
DATE: 
NAME:                                                AGE:                     OP No: 
OBSTETRIC CODE:  
LMP:                                                    EDD: 
ADDRESS & CONTACT NO:  
 
 
 
PRESENTING  COMPLAINTS: 
 
 
MENSTRUAL  HISTORY :  
 
Married since: 
OBSTETRIC HISTORY: 
 
 
PAST HISTORY:   
 
PERSONAL HISTORY:  
 
Vegetarian/ Non vegetarian: 
 
Habit of hand washing: 
 
Personal hygiene: 
 
SOCIO-ECONOMIC HISTORY:  
 Place of residence: 
 
Duration of settlement: 
 
Source of water: 
 
Sewage disposal: 
 
Educational level: 
 
Profession: 
 
Per capita income: 
 
Socio-Economic Status: 
 
GENERAL EXAMINATION: 
HT:                   WT:                         TEMP:                         PR:       BP: 
PALLOR:            ICTERUS:                           PEDAL EDEMA: 
CVS:                                                              RS:                                                           
P/A:                                                                                              
P/V: 
INVESTIGATIONS: 
Hb:                         
RBS:                            
Urine albumin:                            
BLOOD GROUP: 
RFT: 
Urea 
Creatinine 
Na 
K  
LFT: 
Br/D 
SGOT/PT 
ALP 
PT/INR 
IgM Anti-HEV ELISA: 
IgG anti-HEV ELISA: 
Quantitaive Real time PCR of HEV RNA 
 
  
96 well MICROTITRE PLATE 
DATA SHEET 
 
 
 
PC – Positive control 
NC – negative control 
IC – Internal control 
 
  
 1 2 3 4 5 6 7 8 9 10 11 12 
A PC S6 S14 S22 S30 S38 S46 S54 S62 S70 S78 S86 
B NC S7 S15 S23 S31 S39 S47 S55 S63 S71 S79 S87 
C NC S8 S16 S24 S32 S40 S48 S56 S64 S72 S80 S88 
D S1 S9 S17 S25 S33 S41 S49 S57 S65 S73 S81 S89 
E S2 S10 S18 S26 S34 S42 S50 S58 S66 S74 S82 S90 
F S3 S11 S19 S27 S35 S43 S51 S59 S67 S75 S83 S91 
G S4 S12 S20 S28 S36 S44 S52 S60 S68 S76 S84 S92 
H S5 S13 S21 S29 S37 S45 S53 S61 S69 S77 S85 S93 
NATURE ONATURE OF THE REAGENTS: 
HEV Ag coated strips: 
 Polystyrene stripped 96 wells plate (breakable) coated with mix of 
recombinant antigens of HEV. Stored at 2-8° C until expiration date. 
Sample diluent: 
 Transparent or slightly opalescent liquid, violet-blue coloured, 
sediment may form which completely dissolves at shaking. Preserving 
agent: 0.01% thimerosal. Store at 2-8° C until expiration date. 
Conjugate concentrated 21-fold: 
 Monoclonal mouse antibodies against human IgM, labled 
horseradish peroxidase. Transparent or slightly opalescent liquid, light 
yellow colored. Preserving agent: 0.04% ProClin 300, 0.04% gentamycin 
sulfate. Store at 2-8° C until expiration date in a tightly sealed vial 
Conjugate diluent: 
 Transparent, yellow liquid at temperature of 2-8° C, opalescent 
yellow color liquid at temperature of 18-24°C. preserving agent: 
Preserving agent: 0.01% thimerosal. Store at 2-8° C until expiration date 
in a tightly sealed vial. 
  
Positive control: 
 Heat inactivated human serum positive for anti-HEV-IgM, negative 
for anti-HIV-1,2, HBsAg and anti-HCV. Transparent or slightly 
opalescent liquid, red colored. Preserving agent: 0.04% ProClin 300, 
0.1% sodium azide. Store at 2-8°C until expiration date in a tightly sealed 
vial. 
Negative control: 
 Heat inactivated human serum positive for anti-HEV-IgM, negative 
for anti-HIV-1,2, HBsAg and anti-HCV. Transparent or slightly 
opalescent liquid, green colored. Preserving agent: 0.01% thiomersal , 
0.1% sodium azide. Store at 2-8°C until expiration date in a tightly sealed 
vial. 
Washing solution (concentrated 25 fold) 
 Transparent or slightly opalescent liquid, colorless, or pale yellow, 
sediment may form that dissolves at 35-39°C and shaking. Store at 2-8°C 
until expiration date in a tightly sealed vial. 
Substrate buffer: 
 Citric acid and sodium acetate solution, pH 4.1-4.3, containing 
H2O2 . Transparent colorless liquid. Preserving agent: 0.04% ProClin 300. 
Store at 2-8°C until expiration date in a tightly sealed vial. 
TMB concentrated 21- folds: 
 Solution containing Tetramethylbenzidine (TMB). Transparent 
colorless liquid. Store at 2-8°C until expiration date in a tightly sealed 
vial. 
Stopping reagent: 
 0.2M/L sulphuric acid solution. Transparent colorless liquid. Store 
at 2-8°C until expiration date in a tightly sealed vial. 
DS-EIA-ANTI-G 
NATURE OF THE REAGENTS: 
HEV Ag coated strips: 
 Polystyrene stripped 96 wells plate (breakable) coated with mix of 
recombinant antigens of HEV. Stored at 2-8° C until expiration date. 
Sample diluent: 
 Transparent or slightly opalescent liquid, violet-blue coloured, 
sediment may form which completely dissolves at shaking. Preserving 
agent: 0.01% thimerosal. Store at 2-8° C until expiration date. 
Conjugate concentrated 21-fold: 
 Monoclonal mouse antibodies against human IgG, labled 
horseradish peroxidase. Transparent or slightly opalescent liquid, light 
yellow colored. Preserving agent: 0.04% ProClin 300, 0.04% gentamycin 
sulfate. Store at 2-8° C until expiration date in a tightly sealed vial 
Conjugate diluent: 
 Transparent, yellow liquid at temperature of 2-8° C, opalescent 
yellow color liquid at temperature of 18-24°C. Preserving agent: 
Preserving agent: 0.01% thimerosal. Store at 2-8° C until expiration date 
in a tightly sealed vial. 
Positive control: 
 Heat inactivated human serum positive for anti-HEV-IgG, negative 
for anti-HIV-1,2, HBsAg and anti-HCV. Transparent or slightly 
opalescent liquid, red colored. Preserving agent: 0.04% ProClin 300, 
0.1% sodium azide. Store at 2-8°C until expiration date in a tightly sealed 
vial. 
Negative control: 
 Heat inactivated human serum positive for anti-HEV-IgG, negative 
for anti-HIV-1,2, HBsAg and anti-HCV. Transparent or slightly 
opalescent liquid, green colored. Preserving agent: 0.01% thiomersal, 
0.1% sodium azide. Store at 2-8°C until expiration date in a tightly sealed 
vial. 
Washing solution (concentrated 25 fold) 
 Transparent or slightly opalescent liquid, colorless, or pale yellow, 
sediment may form that dissolves at 35-39°C and shaking. Store at 2-8°C 
until expiration date in a tightly sealed vial. 
Substrate buffer: 
 Citric acid and sodium acetate solution, pH 4.1-4.3, containing 
H2O2 . Transparent colorless liquid. Preserving agent: 0.05% ProClin 300. 
Store at 2-8°C until expiration date in a tightly sealed vial. 
TMB concentrated 21- folds: 
 Solution containing Tetramethylbenzidine (TMB). Transparent 
colorless liquid. Store at 2-8°C until expiration date in a tightly sealed 
vial. 
Stopping reagent: 
 0.75 M/L sulphuric acid solution. Transparent colorless liquid. 
Store at 2-8°C until expiration date in a tightly sealed vial. 
 
 
 
  
  
 
 
 
 
 
  
  
 
  
  
 CONSENT FORM 
I agree to participate in the study entitled “A study on the 
assessment of prevalence and severity of Hepatitis E infection in 
pregnancy” 
I confirm that I have been told about this study in my mother 
tongue and have had the opportunity to clarify my doubts. 
I understand that my participation is voluntary and I may refuse to 
participate at any time without giving any reasons and without affecting 
my benefits. 
I agree not to restrict the use of any data or results that arise from 
this study. 
 
Name of the participant : 
 
Sign / Thumb print: 
 
Sign of Investigator : 
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1 23 1 1 1 0 0 0 12 10 1 1 1 1 1 1 1 1 3 9.9 100 1 12 0.6 0.4 13 17 199 10 0 0
2 24 0.33 1 1 0 0 0 4 11 1 2 1 1 1 1 1 1 4 9.5 145 3 34 0.8 0.7 33 23 340 16 0 0
3 20 0.66 1 1 0 0 0 8 8 1 2 1 1 1 1 1 3 4 9.4 120 3 11 0.9 0.9 34 12 360 15 0 0
4 25 10 2 2 1 1 0 60 4 1 2 1 1 0 1 1 4 3 14 100 1 23 0.8 0.5 23 56 340 14 0 0
5 27 27 1 1 0 0 0 3 5 1 2 0 1 0 0 1 1 4 8.8 120 1 33 0.9 0.8 56 23 452 12 1 1
6 19 0.41 1 1 0 0 0 9 14 2 2 1 1 0 1 1 3 4 11 94 3 44 0.8 0.6 22 24 233 18 0 0
7 21 1 2 3 0 0 2 12 12 1 2 1 1 1 1 1 3 3 12 99 7 44 0.8 0.9 44 54 340 16 0 0
8 23 1 1 1 0 0 0 12 15 2 2 1 2 0 1 1 5 3 9.9 90 1 22 0.9 0.8 22 33 440 14 0 0
9 22 0.66 1 1 0 0 0 8 26 3 1 1 3 1 1 2 4 2 10 86 1 22 0.4 0.8 43 46 390 12 0 0
10 19 1 1 1 0 0 0 12 22 2 1 1 1 1 1 1 1 3 9.4 92 1 21 0.6 0.9 35 23 400 14 0 0
11 29 29 2 3 1 1 1 120 28 3 1 0 1 1 1 1 1 3 12 108 3 20 0.5 0.4 28 62 340 11 0 0
12 22 0.83 1 1 0 0 0 10 21 2 1 1 3 1 1 1 4 3 11 86 7 14 0.5 0.3 22 47 280 12 0 0
13 31 5 2 2 1 1 0 108 18 2 1 1 3 1 1 1 3 3 9.6 88 3 16 0.5 0.8 22 34 380 10 0 0
14 22 2.5 2 2 1 1 0 36 26 3 1 1 3 1 1 1 4 3 9.8 89 8 26 0.3 0.4 46 22 330 12 0 0
15 29 1 1 1 0 0 0 12 26 3 1 0 3 1 1 1 3 3 9.3 85 7 16 0.4 0.8 33 24 400 10 0 0
16 23 3 2 3 2 2 0 84 28 3 2 1 3 1 1 1 2 3 10 80 3 22 0.8 0.3 34 58 342 12 0 0
17 24 5 2 2 1 1 0 60 30 3 2 1 1 0 1 1 2 3 9.7 78 7 23 0.7 0.5 23 21 289 11 0 0
18 21 3 2 2 1 1 0 36 6 1 2 1 1 0 1 1 2 3 9.8 76 7 24 0.6 0.9 22 34 390 10 0 0
19 25 3 1 1 0 0 0 3 8 1 1 0 1 1 1 1 4 2 10 90 3 40 0.3 0.4 37 29 420 10 0 1
20 21 10 1 1 0 0 0 12 22 2 2 1 2 1 1 1 1 3 10 75 3 18 0.4 0.3 72 38 310 11 0 0
21 26 4 2 2 1 1 0 48 26 3 1 1 2 1 1 1 4 3 10 85 3 24 0.5 0.9 37 24 390 11 0 0
22 20 1 1 1 0 0 0 9 30 3 1 1 1 1 1 1 1 4 11 86 7 14 0.5 0.8 28 30 400 10 0 0
23 23 4 2 2 1 1 0 48 22 2 1 1 1 1 1 1 2 4 11 92 7 20 0.9 0.6 22 46 450 10 0 0
24 21 22 1 1 0 0 0 12 23 2 1 0 1 0 0 1 2 4 10 91 3 15 0.4 1.1 23 45 330 13 0 0
25 22 22 2 3 2 0 0 36 23 2 1 1 1 0 0 1 1 4 9.8 96 7 20 0.7 0.8 39 35 390 10 0 0
26 22 3 2 3 2 1 0 36 24 2 2 1 1 0 1 1 2 3 9.8 80 3 16 0.5 0.5 24 28 400 10 0 0
27 22 1 1 1 0 0 0 12 26 3 1 0 2 0 1 1 2 3 10 100 7 12 0.8 0.7 23 12 290 12 0 1
28 24 3 1 1 0 0 0 24 36 3 2 1 1 0 1 1 2 3 11 69 3 25 0.6 0.5 65 45 420 12 0 0
29 22 2 1 1 0 0 0 24 38 3 1 1 2 0 1 3 3 4 9.8 90 7 20 0.9 0.7 25 10 480 11 0 0
30 27 10 2 2 1 1 0 10 37 3 2 0 1 0 1 1 2 4 10 62 7 14 0.2 0.8 22 45 450 10 0 0
31 20 1 1 1 0 0 0 6 24 2 1 1 1 1 1 1 2 4 9.2 88 7 22 0.8 0.4 32 46 280 10 0 0
32 28 6 2 3 1 1 1 60 38 3 1 1 2 0 1 2 1 4 10 90 1 30 0.7 0.6 33 43 320 11 0 0
33 27 1 1 1 0 0 0 12 32 3 2 1 1 1 1 1 1 2 8.9 62 1 12 0.6 0.8 24 30 208 12 0 0
34 27 1 2 2 1 1 0 72 24 2 2 1 3 0 1 1 0 4 8.6 58 1 16 0.5 0.6 24 26 301 10 0 0
35 28 1 1 1 0 0 0 18 38 3 1 1 2 1 1 1 3 4 10 98 7 28 0.7 0.9 28 36 256 11 0 0
36 25 7 2 2 1 1 0 84 30 3 2 1 1 1 1 1 2 4 9.2 78 1 24 0.8 0.6 20 16 268 10 0 0
37 33 11 2 3 2 2 0 120 28 3 2 1 1 0 1 1 2 4 12 79 3 14 0.5 0.9 28 36 362 12 0 0
38 27 10 1 1 0 0 0 24 24 2 1 0 1 1 1 1 0 4 9.6 80 2 14 0.5 0.4 32 40 262 10 0 0
39 36 2 2 2 1 1 0 36 38 3 1 1 1 1 1 1 3 3 9.8 89 7 27 0.5 0.5 34 52 293 11 0 0
40 22 2 1 1 0 0 0 6 14 2 2 1 1 0 1 1 2 3 11 99 3 23 0.4 0.3 21 22 190 10 0 0
41 23 3 1 1 1 0 0 2 38 3 1 1 2 0 1 2 4 3 9 89 3 18 0.4 0.2 19 18 200 11 0 0
42 29 3 1 1 1 0 0 12 38 3 1 1 1 1 1 1 1 3 9.8 100 1 19 0.8 0.3 11 17 190 11 0 0
43 23 3 2 2 1 1 0 60 38 3 1 1 2 1 1 1 3 4 9.4 67 1 29 0.3 0.7 26 36 256 10 0 0
44 27 10 2 4 2 1 1 96 30 3 2 1 1 0 0 1 1 4 9.4 97 1 19 0.8 0.6 43 53 264 13 1 1
45 28 2 1 1 1 0 0 12 36 3 1 1 1 1 1 1 2 4 9.7 99 1 22 0.7 0.8 12 11 180 9 0 0
46 30 7 2 3 2 2 0 84 36 3 1 1 1 0 1 1 1 4 8.7 67 1 19 0.5 0.7 23 24 190 11 0 0
47 24 10 1 1 1 0 0 12 32 3 1 1 1 1 1 1 2 4 9.7 102 3 20 0.8 0.5 12 17 200 10 0 0
48 18 3 1 1 0 0 0 12 14 2 1 0 2 1 1 1 0 4 9.6 100 3 10 0.5 0.1 45 29 400 11 0 0
49 34 4 2 2 1 1 0 48 36 3 1 1 3 0 1 1 1 4 9 89 1 20 0.9 0.7 23 20 380 10 0 0
50 18 2 1 1 0 0 0 24 10 1 1 1 2 1 1 2 5 3 9 88 3 20 0.8 0.3 28 22 190 10 0 0
51 28 2 1 1 0 0 0 24 26 2 2 0 3 1 0 1 2 5 9.4 145 3 12 0.7 0.6 23 16 293 10 1 0
52 24 20 1 1 0 0 0 12 28 2 2 1 3 1 1 1 3 5 14 120 3 34 0.9 0.9 12 14 190 11 0 0
53 27 2 1 1 0 0 0 12 12 1 1 1 3 1 1 1 3 5 8.8 100 7 11 0.5 0.8 56 23 200 11 0 0
54 24 2 1 1 0 0 0 18 10 1 2 1 3 1 1 1 3 5 11 120 7 23 0.8 0.8 23 24 190 13 0 0
55 26 5 1 1 0 0 0 8 12 1 2 0 3 0 0 1 0 5 12 94 7 33 0.6 0.9 24 25 256 12 1 0
56 24 2 1 1 0 0 0 36 36 3 2 0 1 1 1 1 3 3 9.9 99 7 44 0.9 0.4 54 21 264 11 0 0
57 25 6 2 2 0 1 0 84 24 2 1 0 1 1 1 1 3 3 10 90 7 44 0.8 0.3 33 24 180 10 0 0
58 21 3 1 1 1 0 0 12 36 3 1 1 1 1 1 1 3 3 9.4 86 7 22 0.8 0.8 46 35 190 9 0 0
59 25 10 2 2 1 1 0 96 28 2 1 1 1 1 1 1 3 3 12 92 7 22 0.9 0.4 23 26 200 11 0 0
60 28 3 1 1 0 0 0 12 36 3 1 1 1 1 1 1 3 3 11 108 7 21 0.4 0.8 62 45 400 12 0 0
61 22 5 1 1 0 0 0 12 36 3 2 0 2 0 1 1 3 5 9.6 86 4 20 0.3 0.3 47 34 380 12 0 1
62 23 6 2 2 1 1 0 60 36 3 1 1 2 1 0 1 3 3 9.8 88 3 14 0.8 0.5 34 22 190 12 0 0
63 30 12 2 2 1 0 0 108 12 1 2 0 2 0 1 1 3 5 9.3 89 7 16 0.4 0.9 22 12 340 15 1 1
64 30 10 2 2 0 1 0 96 28 2 1 1 3 1 1 1 3 3 10 85 7 26 0.8 0.4 24 13 280 12 0 0
65 25 8 2 2 1 1 0 72 32 3 1 1 3 1 1 1 3 3 9.7 80 7 16 0.3 0.3 58 15 380 11 0 0
66 22 6 2 2 1 1 0 60 34 3 1 1 3 1 1 1 2 3 9.8 78 7 22 0.5 0.9 21 23 330 11 0 0
67 21 1 1 1 0 0 0 12 27 2 1 1 3 1 0 1 2 3 10 76 2 23 0.9 0.8 34 21 400 13 0 0
68 23 15 2 3 1 1 1 120 39 3 1 1 3 1 0 1 2 3 10 90 2 24 0.4 0.6 29 54 342 13 0 0
69 27 1 1 1 0 0 0 12 38 3 1 1 3 1 0 1 4 3 10 75 1 40 0.3 1.1 38 34 289 12 0 0
70 22 3 1 1 0 0 0 24 40 3 1 1 3 1 0 1 4 3 11 85 1 18 0.9 0.8 24 24 390 10 0 0
71 21 3 1 1 0 0 0 24 28 2 1 1 3 1 1 1 4 4 11 86 3 24 0.8 0.5 30 27 420 11 0 0
72 26 5 1 1 0 0 0 12 38 3 2 0 1 0 0 2 3 4 10 92 7 14 0.6 0.7 46 23 310 11 1 0
73 23 14 2 2 1 1 0 60 38 3 2 1 3 1 1 1 4 2 9.8 91 7 20 1.1 0.5 45 12 390 13 0 0
74 28 4 1 1 0 0 0 18 32 3 2 1 3 1 1 1 4 2 9.8 96 7 15 0.8 0.7 35 34 400 12 0 0
75 28 9 2 2 1 1 0 96 28 2 2 1 3 1 1 1 4 2 10 80 7 20 0.5 0.8 28 35 450 11 0 0
76 26 2 1 1 0 0 0 18 39 3 1 1 3 1 1 1 4 2 11 100 7 16 0.7 0.4 12 33 330 13 0 0
77 22 3 2 2 1 1 0 60 38 3 1 1 3 1 1 1 4 2 9.8 69 3 12 0.5 0.6 45 33 390 12 0 0
78 18 2 1 1 0 0 0 12 38 3 1 1 3 1 1 1 3 3 10 90 3 25 0.7 0.8 10 35 400 11 0 0
79 23 5 1 1 0 0 0 30 39 3 1 1 3 1 1 1 3 3 9.2 62 3 20 0.8 0.6 45 37 290 10 0 0
80 22 2 1 1 0 0 0 8 28 2 2 1 3 1 1 1 3 3 10 88 3 14 0.4 0.9 46 12 420 14 0 0
81 22 5 1 1 0 0 0 36 39 3 2 1 1 1 1 1 3 3 8.9 90 3 22 0.6 0.6 43 15 480 12 0 0
82 25 15 2 3 2 2 0 120 28 2 2 0 1 0 0 2 3 4 8.6 62 3 30 0.8 0.9 30 19 450 11 0 1
83 30 9 2 2 1 1 0 84 20 2 2 0 1 1 1 1 2 3 10 58 1 12 0.4 0.4 26 34 280 10 0 0
84 28 3 2 2 0 0 1 24 24 2 2 0 1 1 0 1 2 3 9.2 98 3 16 0.4 0.5 36 56 320 11 0 0
85 21 4 1 1 0 0 0 36 26 2 2 1 1 1 0 1 2 3 12 78 2 28 0.8 0.3 16 34 208 12 0 0
86 24 6 2 3 1 1 1 60 20 2 1 1 2 1 1 1 2 3 9.6 79 4 24 0.3 0.2 36 35 301 13 0 0
87 19 1 1 1 0 0 0 12 39 3 1 0 2 1 1 1 2 3 9.8 80 3 14 0.8 0.6 40 45 256 14 0 0
88 35 20 2 3 2 2 0 120 36 3 1 0 2 1 0 1 2 3 11 89 3 14 0.7 0.9 52 46 268 11 0 0
89 25 2 1 1 0 0 0 18 39 3 1 1 1 1 1 1 2 3 9 99 2 27 0.5 0.8 22 19 362 11 0 0
90 32 7 2 2 1 1 0 72 37 3 1 0 1 1 1 1 2 3 9.8 89 1 23 0.8 0.8 18 20 262 12 0 0
91 23 3 1 1 0 0 0 30 36 3 1 0 1 1 0 1 2 3 9.4 100 1 18 0.5 0.9 17 34 254 12 0 0
92 30 1 1 1 0 0 0 12 34 3 2 1 1 0 1 3 2 5 9.4 67 1 19 0.9 0.4 36 12 342 11 0 1
93 21 4 1 1 0 0 0 24 26 2 2 1 1 1 0 1 3 3 9.7 97 1 29 0.8 0.3 53 90 134 10 0 0
94 27 8 1 1 0 0 0 24 36 3 2 1 1 1 1 1 3 3 8.7 99 1 19 0.7 0.8 11 12 34 10 0 0
95 25 3 1 1 0 0 0 12 16 2 1 0 1 1 1 1 3 3 9.7 67 1 22 0.9 0.4 24 12 235 11 0 0
96 23 3 1 1 0 0 0 12 38 3 1 0 1 1 1 1 3 3 9.6 102 1 19 0.5 0.8 17 12 342 12 0 0
97 28 3 2 2 1 1 0 6 26 2 2 0 1 1 1 1 0 2 9 100 1 20 0.8 0.3 29 12 124 11 1 0
98 20 10 2 2 1 1 0 96 34 3 2 0 2 1 0 1 3 3 9 89 7 10 0.6 0.5 20 11 345 11 0 1
99 23 3 1 1 0 0 0 39 30 3 1 1 2 0 1 1 3 3 9.4 88 3 20 0.9 0.9 22 14 234 11 0 0
100 19 6 2 3 1 1 0 84 27 2 1 1 1 0 1 1 3 3 14 145 1 20 0.8 0.4 25 23 433 11 0 0
101 21 8 2 2 1 1 0 84 39 3 1 1 1 0 1 1 3 3 8.8 120 7 12 0.8 0.3 22 12 342 11 0 0
102 23 1 1 1 0 0 0 6 18 2 1 1 1 0 1 1 4 3 11 100 8 34 0.9 0.9 23 13 123 13 0 0
103 22 4 2 2 1 1 0 72 39 3 1 1 1 1 1 1 3 3 12 120 3 11 0.4 0.8 24 24 222 13 0 0
104 27 2 1 1 0 0 0 18 30 3 1 1 1 1 1 1 3 3 9.9 94 5 23 0.3 0.6 23 12 345 12 0 0
105 26 2 1 1 0 0 0 24 34 3 1 1 1 1 1 1 3 3 10 99 7 33 0.8 1.1 22 13 345 13 0 0
106 21 3 1 1 0 0 0 24 39 3 2 1 1 0 0 1 3 3 9.4 90 5 44 0.4 0.8 23 14 344 12 0 1
107 30 5 2 2 1 1 0 48 40 3 1 1 1 0 1 2 3 4 12 86 2 44 0.8 0.5 13 13 666 12 0 0
108 19 10 1 1 0 0 0 12 36 3 1 1 1 0 1 1 4 4 11 92 2 22 0.3 0.7 16 23 233 12 0 0
109 27 8 2 2 1 1 0 72 37 3 1 1 1 1 1 3 3 3 9.6 108 1 22 0.5 0.5 15 25 455 12 0 0
110 27 7 2 4 2 2 1 72 38 3 1 1 1 0 1 3 3 3 9.8 86 1 21 0.9 0.7 23 22 333 12 0 0
111 22 9 2 2 1 1 0 84 32 3 1 1 1 1 1 1 3 3 9.3 88 1 20 0.4 0.8 27 23 453 12 0 0
112 22 8 2 3 1 1 1 84 38 3 2 1 1 0 1 1 3 3 10 89 1 14 0.3 0.4 22 24 233 12 0 0
113 28 10 2 2 1 1 0 96 39 3 1 1 1 0 1 1 3 3 9.7 85 7 16 0.9 0.6 23 23 345 12 0 0
114 26 5 1 1 0 0 0 12 37 3 2 1 1 1 1 1 3 2 9.8 80 7 26 0.8 0.8 23 22 343 11 0 0
115 23 2 1 1 0 0 0 24 30 3 1 1 1 0 1 1 2 3 10 78 7 16 0.6 0.6 25 23 333 11 0 0
116 32 10 1 1 0 0 0 120 35 3 2 1 1 0 1 1 2 3 10 76 3 22 1.1 0.9 32 13 345 11 0 0
117 19 4 1 1 0 0 0 24 36 3 1 1 1 1 1 1 2 3 10 90 3 23 0.8 0.6 16 16 345 12 0 0
118 24 4 1 1 0 0 0 24 26 2 1 1 1 1 1 1 2 2 11 75 3 24 0.5 0.9 45 15 123 11 0 0
119 23 12 2 2 1 1 0 72 20 2 2 1 1 1 1 1 2 2 11 85 3 40 0.7 0.4 43 23 231 10 0 0
120 20 3 1 1 0 0 0 18 37 3 2 1 1 1 1 1 2 2 10 86 6 18 0.5 0.5 47 27 231 13 0 0
121 22 8 2 2 1 1 0 84 36 3 2 1 1 1 0 1 2 2 9.8 92 6 24 0.7 0.3 44 22 222 12 0 0
122 29 9 2 2 1 1 0 84 32 3 2 1 1 1 0 1 2 2 9.8 91 3 14 0.8 0.2 45 23 123 13 0 0
123 20 3 1 1 0 0 0 12 25 2 2 1 1 1 0 3 2 2 10 96 3 20 0.4 0.4 46 23 234 12 0 0
124 21 2 1 1 0 0 0 18 39 3 2 1 1 0 1 1 2 2 11 80 3 15 0.6 0.6 47 12 252 11 0 0
125 22 2 1 1 0 0 0 24 35 3 2 1 1 0 0 1 2 3 9.8 100 3 20 0.8 0.8 44 56 245 11 0 0
126 19 5 1 1 0 0 0 24 38 3 2 1 1 0 0 1 2 2 10 69 3 16 0.4 0.6 41 23 213 10 0 0
127 19 2 1 1 0 0 0 12 10 1 2 1 1 1 0 1 2 4 9.2 90 3 12 0.4 0.9 24 24 218 8 0 1
128 21 4 2 2 1 1 0 60 20 2 1 1 1 0 1 1 2 4 10 62 3 25 0.8 0.6 34 54 229 10 0 0
129 22 8 2 2 1 1 0 72 16 2 1 1 2 0 1 1 1 4 8.9 88 4 20 0.3 0.9 56 33 256 11 0 0
130 19 6 1 1 0 0 0 12 24 2 2 1 1 0 1 1 1 4 8.6 90 7 14 0.8 0.4 34 46 289 12 0 0
131 23 4 2 3 1 1 1 48 12 1 2 1 3 1 1 1 1 4 10 62 7 22 0.7 0.5 38 23 267 13 0 0
132 32 6 2 2 1 1 0 60 24 2 1 1 1 1 1 1 1 4 9.2 58 7 30 0.5 0.3 39 62 280 14 0 0
133 22 5 2 2 1 1 0 48 8 1 1 1 1 1 1 3 2 4 12 98 1 12 0.8 0.2 23 47 230 12 0 0
134 23 3 1 1 0 0 0 24 26 2 1 1 1 1 0 1 1 4 9.6 78 1 16 0.5 0.6 39 34 134 11 0 0
135 26 9 2 3 1 1 1 84 30 3 1 1 1 1 1 1 2 4 9.8 79 1 28 0.9 0.9 22 22 234 10 0 0
136 25 15 2 3 2 2 0 120 28 2 1 1 1 1 1 1 2 4 11 80 7 24 0.8 0.8 33 24 160 12 0 0
137 29 5 2 2 1 1 0 42 14 2 1 0 1 0 1 1 2 4 9 89 7 14 0.7 0.8 44 58 180 12 0 1
138 26 2 1 1 0 0 0 12 16 2 2 1 2 1 0 1 2 4 9.8 99 7 14 0.9 0.9 34 21 149 11 0 0
139 25 3 1 1 0 0 0 24 19 2 2 1 1 1 0 1 3 3 9.4 89 7 27 0.5 0.4 23 34 230 12 0 0
140 21 8 2 2 1 1 0 72 20 2 2 1 1 1 0 1 3 3 9.4 100 7 23 0.8 0.3 33 29 222 13 0 0
141 24 9 2 3 1 1 1 96 12 1 2 1 1 1 0 1 3 3 9.7 67 4 18 0.6 0.8 56 38 234 12 0 0
142 21 10 2 2 1 1 0 84 18 2 2 1 1 1 0 1 3 3 8.7 97 3 19 0.9 0.4 45 24 234 11 0 0
143 21 4 1 1 0 0 0 24 22 2 2 1 1 1 0 1 2 3 9.7 99 7 29 0.8 0.8 61 52 213 10 0 0
144 21 14 1 1 0 0 0 12 24 2 2 0 1 1 0 1 2 3 9.6 67 7 19 0.8 0.9 12 22 234 11 0 0
145 20 4 1 1 0 0 0 42 36 3 2 0 1 1 0 1 3 3 9 102 7 22 0.9 0.6 22 18 234 12 0 0
146 22 4 1 1 0 0 0 36 26 2 1 0 1 1 0 3 3 4 9 100 7 19 0.4 0.9 15 17 213 11 0 0
147 25 10 2 2 1 1 0 120 28 2 1 0 1 1 0 1 3 4 9.4 89 2 20 0.3 0.4 33 36 209 13 0 0
148 30 9 2 3 2 2 0 120 26 2 1 1 1 1 1 1 2 3 14 88 2 10 0.8 0.5 33 53 218 13 0 0
149 25 4 1 1 0 0 0 36 32 3 1 1 1 1 1 1 2 3 8.8 145 1 20 0.4 0.3 33 11 134 13 0 0
150 22 4 1 1 0 0 0 12 34 3 1 1 1 1 1 1 2 3 11 120 1 20 0.8 0.2 45 24 289 14 0 0
151 23 1 1 1 0 0 0 12 20 2 2 1 1 1 1 1 2 2 12 100 3 12 0.3 0.6 62 17 290 14 0 0
152 25 5 2 2 0 0 1 48 14 2 2 1 1 1 1 1 2 4 9.9 120 7 34 0.5 0.9 34 29 245 13 0 0
153 24 4 2 3 0 0 2 36 32 3 1 0 2 0 1 1 2 4 10 94 7 11 0.9 0.8 22 20 221 12 0 1
154 33 13 2 3 2 1 0 150 24 2 1 0 1 1 0 1 3 5 9.4 99 7 23 0.4 0.8 22 22 231 12 0 0
155 21 1 1 1 0 0 0 12 16 2 1 0 1 1 0 1 4 3 12 90 7 33 0.3 0.9 22 16 211 12 0 0
156 24 1 1 1 0 0 0 12 16 2 1 0 1 1 0 1 3 4 11 86 7 44 0.9 0.4 12 14 209 12 0 0
157 21 1 1 1 0 0 0 6 20 2 1 0 1 1 0 1 3 4 9.6 92 3 44 0.8 0.3 12 23 234 12 0 0
158 22 4 2 1 0 0 1 24 18 2 1 0 1 1 0 1 3 3 9.8 108 3 22 0.6 0.8 11 24 221 14 0 0
159 30 1 2 3 2 2 0 48 22 2 1 1 1 1 0 1 3 3 9.3 86 3 22 1.1 0.4 12 25 212 12 0 0
160 21 2 1 1 0 0 0 24 24 2 1 1 1 1 0 1 3 3 10 88 3 21 0.8 0.8 66 21 211 12 0 0
161 21 1 1 1 0 0 0 6 12 1 1 1 1 1 0 3 3 3 9.7 89 3 20 0.5 0.4 16 24 209 12 0 0
162 19 5 1 1 0 0 0 60 14 2 2 1 1 1 0 1 3 3 9.8 85 3 14 0.7 0.4 36 35 208 12 0 0
163 23 4 2 2 1 0 0 48 32 3 2 1 1 1 0 1 3 3 10 80 1 16 0.5 0.8 40 11 211 12 0 0
164 22 6 2 2 1 1 0 72 26 2 2 1 1 1 1 1 3 3 10 78 3 26 0.7 0.3 52 24 231 12 0 0
165 32 12 2 3 1 1 1 120 12 1 1 1 1 1 1 1 3 3 10 76 1 16 0.8 0.8 22 17 220 12 0 0
166 22 1 1 1 0 0 0 8 28 2 1 1 1 1 1 1 3 3 11 90 3 22 0.4 0.7 18 29 231 12 0 0
167 19 5 2 2 0 0 1 60 30 3 1 1 1 1 1 1 3 3 11 75 3 23 0.6 0.5 17 20 213 12 0 0
168 27 7 2 2 0 0 1 84 37 3 1 1 2 1 1 1 3 3 10 85 3 24 0.8 0.8 36 22 245 11 0 0
169 23 9 2 3 2 2 0 120 22 2 2 1 2 1 1 1 3 3 9.8 86 7 40 0.5 0.5 53 22 222 11 0 0
170 23 8 2 2 1 1 0 60 36 3 2 1 1 1 1 1 3 3 9.8 92 7 18 0.7 0.9 11 22 233 12 0 0
171 23 3 1 1 0 0 0 36 28 2 2 1 1 1 1 3 3 3 10 91 7 24 0.8 0.8 24 65 231 11 0 0
172 21 1 1 1 0 0 0 12 36 3 2 1 2 1 1 1 3 3 11 96 7 14 0.4 0.7 17 35 221 12 0 0
173 22 3 1 1 0 0 0 36 13 2 2 1 2 1 1 1 3 3 9.8 80 7 20 0.6 0.9 29 22 222 12 0 0
174 18 1 1 1 0 0 0 12 20 2 2 1 2 1 1 1 3 3 10 100 4 15 0.8 0.5 20 23 213 12 0 0
175 30 10 2 3 2 2 0 120 24 2 2 1 3 1 1 1 3 3 9.2 69 3 20 0.5 0.8 22 22 234 12 0 0
176 22 2 1 1 0 0 0 18 39 3 2 1 3 1 1 1 3 3 10 90 7 16 0.8 0.6 22 25 222 11 0 0
177 21 1 1 1 0 0 0 12 38 3 2 1 3 1 1 1 3 3 8.9 62 7 12 0.7 0.9 22 27 212 11 0 0
178 27 7 2 2 1 1 0 7 28 2 2 1 3 1 1 1 3 4 8.6 88 7 25 0.9 0.8 65 12 211 11 0 0
179 25 10 2 2 1 1 0 96 34 3 1 0 1 0 0 1 0 4 10 90 7 20 0.5 0.8 35 15 234 11 0 0
180 24 2 1 1 0 0 0 24 8 1 2 1 3 1 1 1 2 3 9.2 62 2 14 0.8 0.9 22 17 221 11 0 0
181 25 5 1 1 0 0 0 60 16 2 1 1 3 1 1 1 0 3 12 58 2 22 0.6 0.4 23 33 256 12 0 0
182 23 5 2 3 1 1 1 60 38 3 2 1 3 1 1 1 0 3 9.6 98 1 30 0.9 0.3 22 53 217 11 0 0
183 19 1 1 1 0 0 0 12 38 3 1 1 3 1 1 1 0 3 9.8 78 1 12 0.8 0.8 25 24 433 10 0 0
184 30 12 2 3 0 0 2 120 32 3 2 1 3 1 1 1 0 4 11 79 3 16 0.8 0.4 27 44 256 11 0 0
185 26 12 1 1 0 0 0 8 8 1 2 1 3 1 1 3 0 4 9 80 7 28 0.9 0.8 12 23 289 12 0 0
186 30 5 2 2 1 1 0 60 4 1 2 1 3 1 1 1 0 3 9.8 89 7 24 0.4 0.3 15 22 290 13 0 0
187 22 2 1 1 0 0 0 3 5 1 2 1 3 1 1 1 2 4 9.4 99 7 14 0.3 0.5 17 23 267 11 0 0
188 23 2 1 1 0 0 0 9 14 2 1 1 3 1 1 1 2 3 9.4 89 7 14 0.7 0.9 17 43 290 12 0 0
189 22 5 2 3 0 0 2 12 12 1 1 1 3 1 1 1 2 3 9.7 100 7 27 0.9 0.4 16 23 209 13 0 0
190 23 1 1 1 0 0 0 12 15 2 2 0 3 1 1 3 2 4 8.7 67 3 23 0.5 0.3 18 22 200 14 0 0
191 23 1 1 1 0 0 0 8 26 3 1 1 3 1 1 1 2 4 9.7 97 3 18 0.8 0.9 36 23 276 12 0 0
192 22 1 1 1 0 0 0 12 22 2 2 1 3 1 1 1 2 4 9.6 99 3 19 0.6 0.8 33 34 267 11 0 0
193 23 1 2 3 1 1 1 120 28 3 1 1 3 1 1 1 2 4 9 67 3 29 0.9 0.6 34 54 219 10 0 0
194 24 3 1 1 0 0 0 10 21 2 1 1 3 1 1 1 2 4 9 102 3 19 0.8 1.1 23 34 222 11 0 0
195 25 3 2 2 1 1 0 108 18 2 1 0 1 0 0 1 0 4 8.9 100 3 22 0.8 0.8 23 12 290 10 0 0
196 27 3 2 2 1 1 0 36 26 3 2 1 2 1 1 1 1 3 9 89 1 19 0.9 0.5 34 22 222 10 0 0
197 19 1 1 1 0 0 0 12 26 3 2 1 1 1 1 1 2 3 9.7 88 3 20 0.4 0.7 34 22 212 13 0 0
198 25 4 2 3 2 2 0 84 28 3 1 1 1 1 1 1 3 3 10 89 2 10 0.3 0.5 15 23 211 10 0 0
199 24 3 2 2 1 1 0 60 30 3 2 1 1 1 1 1 4 3 9 99 1 20 0.8 0.7 23 23 234 11 0 0
200 22 1 1 1 0 0 0 12 20 2 1 1 1 1 1 1 4 3 9 90 7 20 0.4 0.8 12 24 221 10 0 0
